<!DOCTYPE html>
<!-- saved from url=(0064)https://bestpractice.bmj.com/topics/en-gb/17/management-approach -->
<html class="">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
      <title>Community-acquired pneumonia - Approach | BMJ Best Practice</title>
      <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
      <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
      <meta name="description" content="Risk factors relate to environment, lifestyle factors, patient status, and comorbidities. Typically characterised by a new lung infiltrate on chest x-ray, together with one or more of the following: fever, chills, cough, sputum production, dyspnoea, myalgia, arthralgia, pleuritic pain. Diagnosis ...">
      <meta name="author" content="Catia Cilloniz">
      <meta name="author" content="Antoni Torres">
      <!-- Optimize Page Hiding Snippet --> 
      <!-- <style>.async-hide
         { opacity: 0 !important}
      </style>
      <script async="" src="./17_diagnosis_management_recommendations_files/adrum-ext.0086dbec5e8a6e717bf36d3a06b62042.js"></script><script src="./17_diagnosis_management_recommendations_files/414393182248444" async=""></script><script async="" src="./17_diagnosis_management_recommendations_files/fbevents.js"></script><script type="text/javascript" async="" src="./17_diagnosis_management_recommendations_files/analytics.js"></script><script async="" src="./17_diagnosis_management_recommendations_files/get-loader.js"></script><script type="text/javascript" async="" src="./17_diagnosis_management_recommendations_files/insight.min.js"></script><script type="text/javascript" async="" src="./17_diagnosis_management_recommendations_files/js"></script><script type="text/javascript" async="" src="./17_diagnosis_management_recommendations_files/uwt.js"></script><script type="text/javascript" async="" src="./17_diagnosis_management_recommendations_files/4896.js"></script><script type="text/javascript" async="" src="./17_diagnosis_management_recommendations_files/analytics.js"></script><script async="" src="./17_diagnosis_management_recommendations_files/gtm.js"></script><script>(function(a,s,y,n,c,h,i,d,e){s.className+=' '+y;h.start=1*new Date; h.end=i=function()
         {s.className=s.className.replace(RegExp(' ?'+y),'')}
         ; (a[n]=a[n]||[]).hide=h;setTimeout(function()
         
         {i();h.end=null}
         ,c);h.timeout=c;})(window,document.documentElement,'async-hide','dataLayer',3000,
         
         {'GTM-K3TZ3JV':true}
         );
      </script> -->
      <!-- end Optimize Page Hiding Snippet -->
      <!-- Google Tag Manager -->
      <script>
         /*<![CDATA[*/
         
          
         window.dataLayer = window.dataLayer || [];
         window.dataLayer.push({
                    'icsId': null,
                    'pi_icsId': "id82087",
                    'pi_icsName': "BMJ Group (Online access from BMA House)",
                    'access_rights': true,
                    'ics_groupings': [{"name":"Country Grouping"}],
                    'ics_countryName': "GB and ROW",
                    'siteLanguage': "en-gb",
                    'contentLanguage': "en-gb"
                 });
         		  
         /*]]>*/
            
      </script>
      <script>
         (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
         new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
         j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
         'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
         })(window,document,'script','dataLayer', 'GTM-K3TZ3JV');
      </script>
      <!-- End Google Tag Manager -->
      <!-- /* if user in China */ -->
      <link rel="stylesheet" type="text/css" media="screen" href="../css/material.css">
      <link rel="stylesheet" type="text/css" media="screen" href="../css/styles.css">
      <link rel="stylesheet" type="text/css" media="screen" href="../css/external.css">
      <link rel="shortcut icon" href="https://resources.bmj.com/repository/images/favicon.ico">
      <link rel="canonical" href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach">
      <link rel="alternate" hreflang="uk-ua" href="https://bestpractice.bmj.com/topics/uk-ua/17/management-approach">
      <link rel="alternate" hreflang="en-ie" href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach">
      <link rel="alternate" hreflang="az-az" href="https://bestpractice.bmj.com/topics/az-az/17/management-approach">
      <link rel="alternate" hreflang="ru" href="https://bestpractice.bmj.com/topics/ru-ru/17/management-approach">
      <link rel="alternate" hreflang="en-us" href="https://bestpractice.bmj.com/topics/en-us/17/management-approach">
      <link rel="alternate" hreflang="pt" href="https://bestpractice.bmj.com/topics/pt-br/17/management-approach">
      <link rel="alternate" hreflang="ka-ge" href="https://bestpractice.bmj.com/topics/ka-ge/17/management-approach">
      <link rel="alternate" hreflang="pt-br" href="https://bestpractice.bmj.com/topics/pt-br/17/management-approach">
      <link rel="alternate" hreflang="es-es" href="https://bestpractice.bmj.com/topics/es-es/17/management-approach">
      <link rel="alternate" hreflang="en" href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach">
      <link rel="alternate" hreflang="zh-cn" href="https://bestpractice.bmj.com/topics/zh-cn/17/management-approach">
      <link rel="alternate" hreflang="es" href="https://bestpractice.bmj.com/topics/es-es/17/management-approach">
      <link rel="alternate" hreflang="zh" href="https://bestpractice.bmj.com/topics/zh-cn/17/management-approach">
      <link rel="alternate" hreflang="x-default" href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach">
      <link rel="alternate" hreflang="ru-ru" href="https://bestpractice.bmj.com/topics/ru-ru/17/management-approach">
      <link rel="alternate" hreflang="vi" href="https://bestpractice.bmj.com/topics/vi-vn/17/management-approach">
      <link rel="alternate" hreflang="uk" href="https://bestpractice.bmj.com/topics/uk-ua/17/management-approach">
      <link rel="alternate" hreflang="ka" href="https://bestpractice.bmj.com/topics/ka-ge/17/management-approach">
      <link rel="alternate" hreflang="az" href="https://bestpractice.bmj.com/topics/az-az/17/management-approach">
      <link rel="alternate" hreflang="vi-vn" href="https://bestpractice.bmj.com/topics/vi-vn/17/management-approach">
      <link rel="alternate" hreflang="en-gb" href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach">
      <!--[if lte IE 9]>
      <link rel="stylesheet" type="text/css" media="screen" href="/gzip_1791a8687c5480ce19e791d0825e7a6b/css/lte-ie-9.css" >
      <![endif]-->
      <script>
         /*<![CDATA[*/
           var appdynamics_app_key="AD-AAB-AAF-RGR";
         /*]]>*/
           	window["adrum-app-key"] = appdynamics_app_key;
           	window['adrum-start-time'] = new Date().getTime();
           
      </script>
      <script type="text/javascript" src="../js/appdynamics.js"></script>
      <script type="application/ld+json">
         [
         
         { "@context": "http://schema.org", "@type": "MedicalCondition" }
         ,{
         "isAccessibleForFree": "False",
         "hasPart":
         
         { "@type": "WebPageElement", "isAccessibleForFree": "False", "cssSelector" : ".gpw" }
         }]
      </script>
      <meta name="msvalidate.01" content="76FD53F39FDFB050A93D7925608BA016">
      <style type="text/css">._6772342E312E39_src-lib-Adapter-styles__centerStyle--2U8wI, ._6772342E312E39_src-lib-Adapter-styles__logo--28R_M, ._6772342E312E39_src-lib-Adapter-styles__presence--30Tio, ._6772342E312E39_src-lib-Adapter-styles__button--3aSCw {
         top: 50%;
         position: absolute;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1 {
         -webkit-user-select: none;
         -moz-user-select: none;
         -ms-user-select: none;
         user-select: none;
         user-drag: none;
         box-sizing: border-box;
         padding: 0;
         border-radius: 3px;
         position: fixed;
         display: block;
         visibility: visible;
         bottom: 0;
         background-color: #f3f3f3;
         transition: visibility 0.2s 0s linear, opacity 0.2s 0s linear, -webkit-transform 0.1s 0s ease-in-out;
         transition: visibility 0.2s 0s linear, opacity 0.2s 0s linear, transform 0.1s 0s ease-in-out;
         transition: visibility 0.2s 0s linear, opacity 0.2s 0s linear, transform 0.1s 0s ease-in-out, -webkit-transform 0.1s 0s ease-in-out;
         z-index: 99999;
         box-shadow: 0px 0px 5px 1px rgba(0, 0, 0, 0.18);
         overflow: hidden;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1._6772342E312E39_src-lib-Adapter-styles__left--1ROKY {
         left: 0;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1._6772342E312E39_src-lib-Adapter-styles__right--2Mb43 {
         right: 0;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1._6772342E312E39_src-lib-Adapter-styles__left--1ROKY {
         left: 0;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1._6772342E312E39_src-lib-Adapter-styles__right--2Mb43 {
         right: 0;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1._6772342E312E39_src-lib-Adapter-styles__left--1ROKY {
         left: 0;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1._6772342E312E39_src-lib-Adapter-styles__right--2Mb43 {
         right: 0;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1._6772342E312E39_src-lib-Adapter-styles__dragging--2uZno {
         transition: opacity 0.1s 0s linear;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1._6772342E312E39_src-lib-Adapter-styles__closed--eHbpJ {
         visibility: hidden;
         opacity: 0;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1._6772342E312E39_src-lib-Adapter-styles__loading--1ewAG {
         display: none;
         }
         ._6772342E312E39_src-lib-Adapter-styles__header--2NQqI {
         -webkit-user-select: none;
         -moz-user-select: none;
         -ms-user-select: none;
         user-select: none;
         user-drag: none;
         position: relative;
         height: 35px;
         line-height: 35px;
         min-width: 165px;
         text-align: center;
         cursor: move;
         z-index: 11;
         overflow: hidden;
         font-family: Helvetica;
         font-weight: normal;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg._6772342E312E39_src-lib-Adapter-styles__header--2NQqI {
         cursor: ew-resize;
         }
         ._6772342E312E39_src-lib-Adapter-styles__logo--28R_M {
         -webkit-user-select: none;
         -moz-user-select: none;
         -ms-user-select: none;
         user-select: none;
         user-drag: none;
         left: 50%;
         height: 16px;
         width: 100px;
         margin-top: -8px;
         margin-left: -50px;
         display: none;
         }
         ._6772342E312E39_src-lib-Adapter-styles__logo--28R_M._6772342E312E39_src-lib-Adapter-styles__visible--VAtK5 {
         display: inline-block;
         }
         ._6772342E312E39_src-lib-Adapter-styles__presence--30Tio {
         left: 20px;
         height: 14px;
         width: 14px;
         border-radius: 8px;
         margin-top: -7px;
         display: none;
         cursor: pointer;
         }
         ._6772342E312E39_src-lib-Adapter-styles__dropdownPresence--18mrh {
         display: none;
         position: absolute;
         width: 100%;
         height: 100vh;
         }
         ._6772342E312E39_src-lib-Adapter-styles__showDropdown--242EQ {
         display: block;
         }
         ._6772342E312E39_src-lib-Adapter-styles__presenceItem--3ODPj {
         padding: 10px 15px;
         display: block;
         cursor: pointer;
         text-decoration: none;
         text-align: left;
         }
         ._6772342E312E39_src-lib-Adapter-styles__presenceItem--3ODPj:hover {
         background-color: #f5f5f5;
         }
         ._6772342E312E39_src-lib-Adapter-styles__selected--1z5-3 {
         color: #0684bd;
         }
         ._6772342E312E39_src-lib-Adapter-styles__line--3f7OM {
         position: relative;
         width: 160px;
         min-width: 165px;
         left: 5px;
         padding: 0;
         min-height: 30px;
         box-sizing: border-box;
         box-shadow: 0 0 4px 0 rgba(0, 0, 0, 0.2);
         background-color: #ffffff;
         border-style: solid;
         border-width: 0;
         border-top-width: 1px;
         border-bottom-width: 0px;
         border-color: #eeeeee;
         border-radius: 4px;
         font-family: "Helvetica Neue", Helvetica, Arial, sans-serif;
         font-size: 14px;
         color: #2F2F2F;
         }
         ._6772342E312E39_src-lib-Adapter-styles__line--3f7OM ._6772342E312E39_src-lib-Adapter-styles__horizontal--1DydQ {
         display: inline-flex;
         }
         ._6772342E312E39_src-lib-Adapter-styles__line--3f7OM ._6772342E312E39_src-lib-Adapter-styles__clickable--G0zEI {
         cursor: pointer;
         }
         ._6772342E312E39_src-lib-Adapter-styles__line--3f7OM ._6772342E312E39_src-lib-Adapter-styles__noborder--1ysDv {
         border: none;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg ._6772342E312E39_src-lib-Adapter-styles__presence--30Tio {
         left: 10px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__Offline--3PnxB {
         display: block;
         background: #cdcdcd;
         }
         ._6772342E312E39_src-lib-Adapter-styles__Busy--IDedL {
         display: block;
         background: #f95b5c;
         }
         ._6772342E312E39_src-lib-Adapter-styles__Available--2GLYE {
         display: block;
         background-color: #32ae31;
         }
         ._6772342E312E39_src-lib-Adapter-styles__presenceBar--1TIQL {
         display: none;
         position: absolute;
         width: 8px;
         height: 2px;
         border-radius: 1.5px;
         background-color: #ffffff;
         -webkit-transform-origin: 50% 50%;
         transform-origin: 50% 50%;
         -webkit-transform: translate(3px, 6px);
         transform: translate(3px, 6px);
         }
         ._6772342E312E39_src-lib-Adapter-styles__DoNotAcceptAnyCalls--1WuKo {
         display: block;
         background: #f95b5c;
         }
         ._6772342E312E39_src-lib-Adapter-styles__DoNotAcceptAnyCalls--1WuKo ._6772342E312E39_src-lib-Adapter-styles__presenceBar--1TIQL {
         display: block;
         }
         ._6772342E312E39_src-lib-Adapter-styles__statusIcon--2SoFd {
         display: inline-block;
         position: relative;
         margin-right: 5px;
         top: 2px;
         left: 0;
         margin-top: 0;
         }
         ._6772342E312E39_src-lib-Adapter-styles__button--3aSCw {
         box-sizing: border-box;
         height: 20px;
         width: 20px;
         margin-top: -12px;
         border-radius: 3px;
         cursor: pointer;
         border-style: solid;
         border-width: 1px;
         border-color: transparent;
         }
         ._6772342E312E39_src-lib-Adapter-styles__button--3aSCw:hover {
         border-color: #cccccc;
         }
         ._6772342E312E39_src-lib-Adapter-styles__toggle--2EHo_ {
         right: 40px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg ._6772342E312E39_src-lib-Adapter-styles__toggle--2EHo_ {
         right: 3px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimizeIcon--NnVNt {
         position: absolute;
         box-sizing: border-box;
         left: 3px;
         bottom: 7px;
         width: 12px;
         height: 2px;
         border: 1px solid #888888;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg ._6772342E312E39_src-lib-Adapter-styles__minimizeIcon--NnVNt {
         height: 12px;
         bottom: 3px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimizeIconBar--2WYhn {
         width: 100%;
         height: 1px;
         background-color: #888888;
         }
         ._6772342E312E39_src-lib-Adapter-styles__close--1qEO1 {
         right: 16px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg ._6772342E312E39_src-lib-Adapter-styles__close--1qEO1 {
         display: none;
         }
         ._6772342E312E39_src-lib-Adapter-styles__closeIcon--gYGuR {
         position: relative;
         overflow: hidden;
         margin: 2px;
         width: 14px;
         height: 14px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__closeIcon--gYGuR :first-child, ._6772342E312E39_src-lib-Adapter-styles__closeIcon--gYGuR :last-child {
         position: absolute;
         height: 2px;
         width: 100%;
         top: 6px;
         left: 0;
         background: #888888;
         border-radius: 1px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__closeIcon--gYGuR :first-child {
         -webkit-transform: rotate(45deg);
         transform: rotate(45deg);
         }
         ._6772342E312E39_src-lib-Adapter-styles__closeIcon--gYGuR :last-child {
         -webkit-transform: rotate(-45deg);
         transform: rotate(-45deg);
         }
         ._6772342E312E39_src-lib-Adapter-styles__contentFrame--Z6dLx {
         display: block;
         border: none;
         width: 0;
         height: 0;
         }
         ._6772342E312E39_src-lib-Adapter-styles__frameContainer--Wtvcz {
         overflow: hidden;
         transition: width 0.1s 0s ease-in-out, height 0.1s 0s ease-in-out;
         }
         @-webkit-keyframes _6772342E312E39_src-lib-Adapter-styles__glow--1aZft {
         0% {
         box-shadow: inset 0 0 7px -10px #0684bd;
         }
         40%, 50% {
         box-shadow: inset 0 0 7px 0px #0684bd;
         }
         100% {
         box-shadow: inset 0 0 7px -10px #0684bd;
         }
         }
         @keyframes _6772342E312E39_src-lib-Adapter-styles__glow--1aZft {
         0% {
         box-shadow: inset 0 0 7px -10px #0684bd;
         }
         40%, 50% {
         box-shadow: inset 0 0 7px 0px #0684bd;
         }
         100% {
         box-shadow: inset 0 0 7px -10px #0684bd;
         }
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg._6772342E312E39_src-lib-Adapter-styles__ringing--2c7d0 {
         -webkit-animation-name: _6772342E312E39_src-lib-Adapter-styles__glow--1aZft;
         animation-name: _6772342E312E39_src-lib-Adapter-styles__glow--1aZft;
         -webkit-animation-duration: 2s;
         animation-duration: 2s;
         -webkit-animation-timing-function: ease-in-out;
         animation-timing-function: ease-in-out;
         -webkit-animation-iteration-count: infinite;
         animation-iteration-count: infinite;
         }
         @-webkit-keyframes _6772342E312E39_src-lib-Adapter-styles__moveIn--339sz {
         0% {
         display: none;
         top: -50%;
         }
         100% {
         display: inline-block;
         top: 50%;
         }
         }
         @keyframes _6772342E312E39_src-lib-Adapter-styles__moveIn--339sz {
         0% {
         display: none;
         top: -50%;
         }
         100% {
         display: inline-block;
         top: 50%;
         }
         }
         @-webkit-keyframes _6772342E312E39_src-lib-Adapter-styles__moveOut--FFYLa {
         0% {
         display: inline-block;
         top: 50%;
         }
         100% {
         top: 150%;
         display: none;
         }
         }
         @keyframes _6772342E312E39_src-lib-Adapter-styles__moveOut--FFYLa {
         0% {
         display: inline-block;
         top: 50%;
         }
         100% {
         top: 150%;
         display: none;
         }
         }
         ._6772342E312E39_src-lib-Adapter-styles__moveIn--339sz {
         -webkit-animation-name: _6772342E312E39_src-lib-Adapter-styles__moveIn--339sz;
         animation-name: _6772342E312E39_src-lib-Adapter-styles__moveIn--339sz;
         -webkit-animation-duration: 1s;
         animation-duration: 1s;
         -webkit-animation-timing-function: ease-in-out;
         animation-timing-function: ease-in-out;
         -webkit-animation-iteration-count: 1;
         animation-iteration-count: 1;
         -webkit-animation-fill-mode: forwards;
         animation-fill-mode: forwards;
         }
         ._6772342E312E39_src-lib-Adapter-styles__moveOut--FFYLa {
         -webkit-animation-name: _6772342E312E39_src-lib-Adapter-styles__moveOut--FFYLa;
         animation-name: _6772342E312E39_src-lib-Adapter-styles__moveOut--FFYLa;
         -webkit-animation-duration: 1s;
         animation-duration: 1s;
         -webkit-animation-timing-function: ease-in-out;
         animation-timing-function: ease-in-out;
         -webkit-animation-iteration-count: 1;
         animation-iteration-count: 1;
         -webkit-animation-fill-mode: forwards;
         animation-fill-mode: forwards;
         }
         ._6772342E312E39_src-lib-Adapter-styles__duration--3PGiS._6772342E312E39_src-lib-Adapter-styles__visible--VAtK5, ._6772342E312E39_src-lib-Adapter-styles__ringingCalls--2-nNV._6772342E312E39_src-lib-Adapter-styles__visible--VAtK5, ._6772342E312E39_src-lib-Adapter-styles__onHoldCalls--3TETV._6772342E312E39_src-lib-Adapter-styles__visible--VAtK5 {
         top: 50%;
         }
         ._6772342E312E39_src-lib-Adapter-styles__duration--3PGiS {
         position: absolute;
         top: -50%;
         left: 50%;
         height: 16px;
         line-height: 16px;
         margin-top: -8px;
         color: #666666;
         font-size: 12px;
         white-space: nowrap;
         width: 33px;
         margin-left: -60px;
         cursor: pointer;
         }
         ._6772342E312E39_src-lib-Adapter-styles__duration--3PGiS._6772342E312E39_src-lib-Adapter-styles__center--3fFya {
         margin-left: -16px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__ringingCalls--2-nNV, ._6772342E312E39_src-lib-Adapter-styles__onHoldCalls--3TETV {
         position: absolute;
         top: -50%;
         left: 50%;
         height: 16px;
         line-height: 16px;
         margin-top: -8px;
         color: #666666;
         font-size: 12px;
         white-space: nowrap;
         width: 100px;
         margin-left: -100px;
         text-overflow: ellipsis;
         overflow: hidden;
         text-align: center;
         }
         ._6772342E312E39_src-lib-Adapter-styles__ringingCalls--2-nNV._6772342E312E39_src-lib-Adapter-styles__center--3fFya, ._6772342E312E39_src-lib-Adapter-styles__onHoldCalls--3TETV._6772342E312E39_src-lib-Adapter-styles__center--3fFya {
         margin-left: -50px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__currentCallBtn--3k6uX {
         position: absolute;
         top: -50%;
         left: 50%;
         padding: 0 5px;
         height: 18px;
         line-height: 18px;
         border-radius: 10.5px;
         font-size: 11px;
         margin-top: -10px;
         margin-left: -13px;
         overflow: hidden;
         white-space: nowrap;
         min-width: 66px;
         max-width: 110px;
         cursor: pointer;
         border: solid 1px #5FB95C;
         color: #5FB95C;
         }
         ._6772342E312E39_src-lib-Adapter-styles__currentCallBtn--3k6uX._6772342E312E39_src-lib-Adapter-styles__visible--VAtK5 {
         display: inline-block;
         margin-top: -10px;
         top: 50%;
         }
         ._6772342E312E39_src-lib-Adapter-styles__currentCallBtn--3k6uX:hover {
         color: #5FB95C;
         }
         ._6772342E312E39_src-lib-Adapter-styles__currentCallBtn--3k6uX._6772342E312E39_src-lib-Adapter-styles__left--1ROKY {
         margin-left: -80px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__viewCallsBtn--1W1UL {
         position: absolute;
         top: -50%;
         left: 50%;
         padding: 0 5px;
         height: 18px;
         line-height: 18px;
         border-radius: 10.5px;
         font-size: 11px;
         margin-top: -10px;
         margin-left: -13px;
         overflow: hidden;
         white-space: nowrap;
         min-width: 66px;
         max-width: 110px;
         cursor: pointer;
         border: solid 1px #FF8800;
         color: #FF8800;
         margin-left: 0;
         }
         ._6772342E312E39_src-lib-Adapter-styles__viewCallsBtn--1W1UL:hover {
         color: #FF8800;
         }
         ._6772342E312E39_src-lib-Adapter-styles__viewCallsBtn--1W1UL._6772342E312E39_src-lib-Adapter-styles__visible--VAtK5 {
         display: inline-block;
         margin-top: -10px;
         top: 50%;
         }
         ._6772342E312E39_src-lib-Adapter-styles__detectNew--2RyZg {
         background: url("https://rc-hack-new.detect");
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1 {
         transition: visibility 0.2s 0s linear, opacity 0.2s 0s linear, width 0.2s ease-in-out, -webkit-transform 0.2s 0s ease-in-out;
         transition: visibility 0.2s 0s linear, opacity 0.2s 0s linear, transform 0.2s 0s ease-in-out, width 0.2s ease-in-out;
         transition: visibility 0.2s 0s linear, opacity 0.2s 0s linear, transform 0.2s 0s ease-in-out, width 0.2s ease-in-out, -webkit-transform 0.2s 0s ease-in-out;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1._6772342E312E39_src-lib-Adapter-styles__dock---5JfC {
         top: initial !important;
         width: 300px;
         border-top-right-radius: 0;
         border-bottom-right-radius: 0;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1._6772342E312E39_src-lib-Adapter-styles__dock---5JfC._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg {
         width: 60px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__root--SzEr1._6772342E312E39_src-lib-Adapter-styles__dock---5JfC._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg._6772342E312E39_src-lib-Adapter-styles__noPresence--gCXYu {
         width: 35px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__iconTrans--2LRAZ ._6772342E312E39_src-lib-Adapter-styles__presence--30Tio {
         opacity: 1 !important;
         }
         ._6772342E312E39_src-lib-Adapter-styles__iconTrans--2LRAZ ._6772342E312E39_src-lib-Adapter-styles__iconContainer--2u4Jv {
         opacity: 0 !important;
         }
         ._6772342E312E39_src-lib-Adapter-styles__iconTrans--2LRAZ ._6772342E312E39_src-lib-Adapter-styles__logo--28R_M {
         opacity: 1 !important;
         }
         ._6772342E312E39_src-lib-Adapter-styles__iconContainer--2u4Jv {
         display: none;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg._6772342E312E39_src-lib-Adapter-styles__expandable--1dLZX {
         width: 140px !important;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg._6772342E312E39_src-lib-Adapter-styles__header--2NQqI {
         line-height: initial;
         cursor: pointer;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg ._6772342E312E39_src-lib-Adapter-styles__presence--30Tio {
         width: 12px;
         height: 12px;
         margin-top: -6px;
         z-index: 2;
         transition: .2s;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg ._6772342E312E39_src-lib-Adapter-styles__presenceBar--1TIQL {
         -webkit-transform: translate(2px, 5px);
         transform: translate(2px, 5px);
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg ._6772342E312E39_src-lib-Adapter-styles__logo--28R_M._6772342E312E39_src-lib-Adapter-styles__dock---5JfC {
         opacity: 0;
         transition: opacity .2s;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg ._6772342E312E39_src-lib-Adapter-styles__iconContainer--2u4Jv {
         z-index: 2147483648;
         top: 7px;
         position: absolute;
         left: 30px;
         height: 22px;
         width: 22px;
         display: block;
         cursor: pointer;
         opacity: 1;
         transition: .3s;
         display: flex;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg ._6772342E312E39_src-lib-Adapter-styles__iconContainer--2u4Jv ._6772342E312E39_src-lib-Adapter-styles__icon--2I9x4 {
         width: 22px;
         height: 22px;
         display: inline-block;
         }
         ._6772342E312E39_src-lib-Adapter-styles__iconContainer--2u4Jv._6772342E312E39_src-lib-Adapter-styles__noPresence--gCXYu {
         left: 7px !important;
         }
         ._6772342E312E39_src-lib-Adapter-styles__frameContainer--Wtvcz {
         overflow: hidden;
         transition: width 0.2s 0s ease-in-out, height 0.2s 0s ease-in-out;
         }
         ._6772342E312E39_src-lib-Adapter-styles__popOut--2sH2z {
         right: 16px;
         }
         ._6772342E312E39_src-lib-Adapter-styles__minimized--2g_Jg ._6772342E312E39_src-lib-Adapter-styles__popOut--2sH2z {
         display: none;
         }
         ._6772342E312E39_src-lib-Adapter-styles__popOutIcon--oudoy img {
         position: absolute;
         top: 3px;
         left: 1px;
         width: 14px;
         }
      </style>
      <style type="text/css">._6772342E312E39_src-lib-ExtensionContentRunner-styles__c2dMenu--2ChJF {
         -webkit-user-select: none;
         -moz-user-select: none;
         -ms-user-select: none;
         user-select: none;
         user-drag: none;
         display: none;
         height: 30px;
         left: 0;
         position: fixed;
         top: 0;
         -webkit-transform: opacity 0.1s 0s linear;
         transform: opacity 0.1s 0s linear;
         z-index: 999999999;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__c2dMenuWrapper--2XS05 {
         -webkit-user-select: none;
         -moz-user-select: none;
         -ms-user-select: none;
         user-select: none;
         user-drag: none;
         background-color: rgba(255, 255, 255, 0.95);
         box-sizing: border-box;
         border: 1px solid #cfcfcf;
         border-radius: 4px;
         font-size: 0px;
         height: 30px;
         white-space: nowrap;
         margin: 0 0 0 5px;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__c2dMenuWrapper--2XS05 img {
         vertical-align: baseline !important;
         display: inline-block !important;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__c2dMenu--2ChJF._6772342E312E39_src-lib-ExtensionContentRunner-styles__left--2MAWB ._6772342E312E39_src-lib-ExtensionContentRunner-styles__c2dMenuWrapper--2XS05 {
         margin: 0 5px 0 0;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__arrow--1GYRr {
         position: absolute;
         border-top: 5px solid transparent;
         border-bottom: 5px solid transparent;
         border-right: 5px solid #cfcfcf;
         top: calc(50% - 5px);
         left: 0;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__innerArrow--2JsQO {
         position: absolute;
         border-top: 5px solid transparent;
         border-bottom: 5px solid transparent;
         border-right: 5px solid #FF8800;
         top: calc(50% - 5px);
         left: 1px;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__c2dMenu--2ChJF._6772342E312E39_src-lib-ExtensionContentRunner-styles__left--2MAWB ._6772342E312E39_src-lib-ExtensionContentRunner-styles__arrow--1GYRr {
         border-right: none;
         border-left: 5px solid #cfcfcf;
         left: initial;
         right: 0;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__c2dMenu--2ChJF._6772342E312E39_src-lib-ExtensionContentRunner-styles__left--2MAWB ._6772342E312E39_src-lib-ExtensionContentRunner-styles__innerArrow--2JsQO {
         border-right: none;
         border-left: 5px solid #fff;
         left: initial;
         right: 1px;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__c2dLogo--3d0gU {
         height: 30px;
         width: 30px;
         margin: -1px 0 0 -1px;
         vertical-align: baseline;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__c2dMenu--2ChJF._6772342E312E39_src-lib-ExtensionContentRunner-styles__visible--1Jw-v {
         display: block;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__btn--2BjPK, ._6772342E312E39_src-lib-ExtensionContentRunner-styles__callBtn--g4JAI, ._6772342E312E39_src-lib-ExtensionContentRunner-styles__smsBtn--b7MAc {
         display: none;
         position: relative;
         vertical-align: top;
         cursor: pointer;
         font-size: 18px;
         height: 28px;
         width: 28px;
         line-height: 28px;
         text-align: center;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__btn--2BjPK:hover, ._6772342E312E39_src-lib-ExtensionContentRunner-styles__callBtn--g4JAI:hover, ._6772342E312E39_src-lib-ExtensionContentRunner-styles__smsBtn--b7MAc:hover {
         opacity: 0.6;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__btn--2BjPK._6772342E312E39_src-lib-ExtensionContentRunner-styles__visible--1Jw-v, ._6772342E312E39_src-lib-ExtensionContentRunner-styles__visible--1Jw-v._6772342E312E39_src-lib-ExtensionContentRunner-styles__callBtn--g4JAI, ._6772342E312E39_src-lib-ExtensionContentRunner-styles__visible--1Jw-v._6772342E312E39_src-lib-ExtensionContentRunner-styles__smsBtn--b7MAc {
         display: inline-block;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__separatorLine--wHeg7 {
         display: none;
         width: 1px;
         height: 19px;
         margin: 5px 0;
         background: #cdcdcd;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__separatorLine--wHeg7:hover {
         opacity: 0.6;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__separatorLine--wHeg7._6772342E312E39_src-lib-ExtensionContentRunner-styles__visible--1Jw-v {
         display: inline-block;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__hack--5AVJK {
         background: url("https://rc-hack-c2d.detect");
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__btn--2BjPK svg, ._6772342E312E39_src-lib-ExtensionContentRunner-styles__callBtn--g4JAI svg, ._6772342E312E39_src-lib-ExtensionContentRunner-styles__smsBtn--b7MAc svg {
         position: absolute;
         top: 50%;
         left: 50%;
         -webkit-transform: translateX(-50%) translateY(-50%);
         transform: translateX(-50%) translateY(-50%);
         overflow: visible !important;
         }
         ._6772342E312E39_src-lib-ExtensionContentRunner-styles__btn--2BjPK svg > path, ._6772342E312E39_src-lib-ExtensionContentRunner-styles__callBtn--g4JAI svg > path, ._6772342E312E39_src-lib-ExtensionContentRunner-styles__smsBtn--b7MAc svg > path {
         fill: #0684bd;
         stroke: #0684bd;
         }
      </style>
      <style type="text/css">add-meeting-button {
         line-height: 36px;
         }
         ._6772342E312E39_src-lib-MeetingHelper-Page-styles__root--3CtVK {
         margin-left: 8px;
         position: relative;
         display: inline-block;
         }
         ._6772342E312E39_src-lib-MeetingHelper-Page-styles__button--sCE0Q {
         min-width: 94px;
         white-space: nowrap;
         height: 26px;
         line-height: 26px;
         padding: 0;
         font-size: 11px;
         font-weight: 500;
         text-align: center;
         color: #0684bd;
         background: #fff;
         border-radius: 20px;
         border: 1px solid #9bcee5;
         font-family: Roboto, Helvetica, Arial, sans-serif;
         font-weight: 400;
         outline: none;
         cursor: pointer;
         transition: .3s;
         display: none;
         }
         ._6772342E312E39_src-lib-MeetingHelper-Page-styles__button--sCE0Q:hover {
         color: #fff;
         background-color: #9bcee5;
         }
         ._6772342E312E39_src-lib-MeetingHelper-Page-styles__button--sCE0Q._6772342E312E39_src-lib-MeetingHelper-Page-styles__disabled--12Fo1 {
         color: #fff;
         background-color: #c7c7c7;
         border: 1px solid #c7c7c7;
         cursor: default;
         }
         ._6772342E312E39_src-lib-MeetingHelper-Page-styles__button--sCE0Q._6772342E312E39_src-lib-MeetingHelper-Page-styles__disabled--12Fo1:hover {
         cursor: default;
         background-color: #c7c7c7;
         }
         ._6772342E312E39_src-lib-MeetingHelper-Page-styles__or--Hsdgj {
         float: left;
         margin-left: 10px;
         font-size: 12px;
         color: #0684bd;
         display: none;
         }
         ._6772342E312E39_src-lib-MeetingHelper-Page-styles__icon--r7sAL {
         left: 5px;
         top: 4px;
         width: 18px;
         height: 18px;
         position: absolute;
         background: #fff;
         border-radius: 100%;
         }
         ._6772342E312E39_src-lib-MeetingHelper-Page-styles__text--1nLnV {
         width: 100%;
         margin-left: 25px;
         padding-right: 6px;
         }
         ._6772342E312E39_src-lib-MeetingHelper-Page-styles__meetingContainer--24va2 {
         display: flex;
         flex-grow: 100;
         align-items: center;
         }
      </style>
      <style type="text/css">#rc-meeting-popup-window {
         width: 100%;
         height: 100%;
         background-color: rgba(0, 0, 0, 0.3);
         display: flex;
         justify-content: center;
         align-items: center;
         line-height: normal;
         text-align: left;
         position: fixed;
         z-index: 2147483647;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__container--2qd2O {
         width: 470px;
         height: auto;
         display: flex;
         flex-direction: column;
         align-items: stretch;
         overflow: hidden;
         box-shadow: 0 24px 38px 3px rgba(0, 0, 0, 0.14), 0 9px 46px 8px rgba(0, 0, 0, 0.12), 0 11px 15px -7px rgba(0, 0, 0, 0.2);
         border-radius: 2px;
         position: relative;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__header--axhLA {
         position: relative;
         width: 100%;
         height: 30px;
         line-height: 30px;
         font-size: 12px;
         box-sizing: border-box;
         background: #ffffff;
         padding-left: 15px;
         padding-top: 10px;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__recurringMeetingPrompt--3U97a {
         margin: 5px 22px;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__closeBtn--1JJ_X {
         position: absolute;
         top: 13px;
         right: 15px;
         color: rgba(0, 0, 0, 0.54);
         fill: rgba(0, 0, 0, 0.54);
         width: 20px;
         height: 20px;
         cursor: pointer;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__closeBtn--1JJ_X svg {
         width: 20px;
         height: 20px;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__wrapper--3DttD {
         background-color: #ffffff;
         width: 100%;
         padding: 10px;
         box-sizing: border-box;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__settings--15yhX {
         border-radius: 3px;
         box-sizing: border-box;
         padding: 0 8px;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__categoryLabel--2n8iQ {
         margin: 10px 0;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__categoryWrapper--2LA96 {
         border-radius: 3px;
         background-color: #F9F9F9;
         border: 1px solid #E2E2E2;
         padding: 9px 16px;
         box-sizing: border-box;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__settingLabel--ybCle {
         display: inline-block;
         width: 80px;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__line--359ZF {
         line-height: 20px;
         margin: 7px 0;
         display: flex;
         align-items: center;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__line--359ZF * {
         vertical-align: middle;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__video--1oJss {
         margin-left: 15px;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__audio--2dr2m {
         margin-left: 15px;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__line--359ZF input:first-of-type {
         margin-left: 0;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__controls--1GgrW {
         margin: 10px 0 10px 10px;
         height: 30px;
         line-height: 30px;
         display: flex;
         align-items: center;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__schedule--3SMpg {
         background: #4285f4;
         color: #fff;
         transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
         box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14), 0 3px 1px -2px rgba(0, 0, 0, 0.12), 0 1px 5px 0 rgba(0, 0, 0, 0.2);
         border: 0;
         border-radius: 3px;
         cursor: pointer;
         display: inline-block;
         font-weight: 500;
         outline: none;
         overflow: hidden;
         text-align: center;
         z-index: 0;
         font-size: 12px;
         line-height: 30px;
         height: 32px;
         min-width: 88px;
         position: absolute;
         right: 18px;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__header--axhLA span {
         font-size: 16px;
         display: inline-block;
         }
         ._6772342E312E39_src-lib-MeetingHelper-PopupWindow-styles__password--3Ij_s {
         display: none;
         margin-left: 10px;
         }
      </style>
      <style type="text/css">._6772342E312E39_src-lib-MeetingHelper-Spinner-styles__spinner--18fX2 {
         -webkit-animation: _6772342E312E39_src-lib-MeetingHelper-Spinner-styles__rotator--5WHNP 1.4s linear infinite;
         animation: _6772342E312E39_src-lib-MeetingHelper-Spinner-styles__rotator--5WHNP 1.4s linear infinite;
         }
         @-webkit-keyframes _6772342E312E39_src-lib-MeetingHelper-Spinner-styles__rotator--5WHNP {
         0% {
         -webkit-transform: rotate(0deg);
         transform: rotate(0deg);
         }
         100% {
         -webkit-transform: rotate(270deg);
         transform: rotate(270deg);
         }
         }
         @keyframes _6772342E312E39_src-lib-MeetingHelper-Spinner-styles__rotator--5WHNP {
         0% {
         -webkit-transform: rotate(0deg);
         transform: rotate(0deg);
         }
         100% {
         -webkit-transform: rotate(270deg);
         transform: rotate(270deg);
         }
         }
         ._6772342E312E39_src-lib-MeetingHelper-Spinner-styles__path--2xqMm {
         stroke-dasharray: 187;
         stroke-dashoffset: 0;
         -webkit-transform-origin: center;
         transform-origin: center;
         -webkit-animation: _6772342E312E39_src-lib-MeetingHelper-Spinner-styles__dash--2lb9k 1.4s ease-in-out infinite, _6772342E312E39_src-lib-MeetingHelper-Spinner-styles__colors--26t3q 5.6s ease-in-out infinite;
         animation: _6772342E312E39_src-lib-MeetingHelper-Spinner-styles__dash--2lb9k 1.4s ease-in-out infinite, _6772342E312E39_src-lib-MeetingHelper-Spinner-styles__colors--26t3q 5.6s ease-in-out infinite;
         }
         @-webkit-keyframes _6772342E312E39_src-lib-MeetingHelper-Spinner-styles__colors--26t3q {
         0% {
         stroke: #4285F4;
         }
         25% {
         stroke: #DE3E35;
         }
         50% {
         stroke: #F7C223;
         }
         75% {
         stroke: #1B9A59;
         }
         100% {
         stroke: #4285F4;
         }
         }
         @keyframes _6772342E312E39_src-lib-MeetingHelper-Spinner-styles__colors--26t3q {
         0% {
         stroke: #4285F4;
         }
         25% {
         stroke: #DE3E35;
         }
         50% {
         stroke: #F7C223;
         }
         75% {
         stroke: #1B9A59;
         }
         100% {
         stroke: #4285F4;
         }
         }
         @-webkit-keyframes _6772342E312E39_src-lib-MeetingHelper-Spinner-styles__dash--2lb9k {
         0% {
         stroke-dashoffset: 187;
         }
         50% {
         stroke-dashoffset: 46.75;
         -webkit-transform: rotate(135deg);
         transform: rotate(135deg);
         }
         100% {
         stroke-dashoffset: 187;
         -webkit-transform: rotate(450deg);
         transform: rotate(450deg);
         }
         }
         @keyframes _6772342E312E39_src-lib-MeetingHelper-Spinner-styles__dash--2lb9k {
         0% {
         stroke-dashoffset: 187;
         }
         50% {
         stroke-dashoffset: 46.75;
         -webkit-transform: rotate(135deg);
         transform: rotate(135deg);
         }
         100% {
         stroke-dashoffset: 187;
         -webkit-transform: rotate(450deg);
         transform: rotate(450deg);
         }
         }
      </style>
      <style></style>
   </head>
   <body class="gpw">
      <div role="dialog" aria-live="polite" aria-label="cookieconsent" aria-describedby="cookieconsent:desc" class="cc-window cc-banner cc-type-info cc-theme-classic cc-bottom cc-color-override--38786966 " style="">
         <!--googleoff: all--><span id="cookieconsent:desc" class="cc-message">We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our 
         <a aria-label="learn more about cookies" role="button" tabindex="0" class="cc-link" href="https://www.bmj.com/company/your-privacy/cookies-policy/" target="_blank">cookies policy</a></span>
         <div class="cc-compliance"><a aria-label="dismiss cookie message" role="button" tabindex="0" class="cc-btn cc-dismiss">OK!</a></div>
         <!--googleon: all-->
      </div>
      <!-- Google Tag Manager (noscript) -->
      <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-K3TZ3JV" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
      <!-- End Google Tag Manager (noscript) -->
      <!-- /* if user in China */ -->
      <header id="header" role="banner">
         <a class="sr-only" href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#sr-content">Skip to main content</a>
         <div class="bg-info text-white">
         </div>
         <nav id="globalNav" class="logo-img-mob navbar navbar-toggleable-md">
            <div class="container">
               <a href="https://bestpractice.bmj.com/" class="mobLogo"><span class="remove"><abbr>BMJ</abbr> Best Practice</span></a>
               <button class="navbar-toggler navbar-toggler-right" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation">
               <span class="material-icons"></span>
               </button>
               <div id="navbarNav" class="collapse navbar-collapse">
                  <ul id="globalNav-ul" class="navbar-nav" role="menubar">
                     <li id="globalNav-access" class="nav-item" role="presentation">
                        <span class="nav-link"> 
                        Access provided by: 
                        BMJ Group (Online access from BMA House)
                        </span>
                     </li>
                     <li id="globalNav-help" class="nav-item dropdown" role="menuitem">
                        <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" id="navbarDropdownMenuLink02" class="nav-link dropdown-toggle" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false"> 
                        Help <span class="states">
                        <span class="material-icons"></span>
                        <span class="material-icons"></span>
                        </span>
                        </a>
                        <div id="globalNav-help-options" class="dropdown-menu dropdown-menu-right" aria-labelledby="navbarDropdownMenuLink02">
                           <span class="material-icons"></span>
                           <ul role="menu">
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/getting-started/" target="_blank">Getting started</a></li>
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/faq/" target="_blank">FAQs</a></li>
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/benefits-features/earn-cme-points/" target="_blank">About CME/CPD</a></li>
                              <li class="dropdown-item"><a href="https://bestpractice.bmj.com/info/contact-us/" target="_blank">Contact us</a></li>
                           </ul>
                        </div>
                     </li>
                     <li id="globalNav-register" class="nav-item">
                        <a href="https://bestpractice.bmj.com/registration" class="nav-link">Create account</a>
                     </li>
                     <li id="globalNav-login" class="nav-item">
                        <a href="https://bestpractice.bmj.com/login" class="nav-link">Log in</a>
                     </li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/recent-updates"><span class="icon icon-bp-icons-recent-updates"></span><span>Recent updates</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/specialties"><span class="icon icon-bp-icons-specialties"></span><span>Specialties</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/calculators"><span class="icon icon-bp-icons-calculators"></span><span>Calculators</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/patient-leaflets"><span class="icon icon-bp-icons-patient-leaflets"></span><span>Patient leaflets</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/procedural-videos"><span class="icon icon-bp-icons-procedural-videos"></span><span>Procedural videos</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/evidence"><span class="icon icon-bp-icons-evidence"></span><span>Evidence</span></a></li>
                     <li class="nav-item main" role="menuitem" hidden="hidden"><a class="nav-link" href="https://bestpractice.bmj.com/drugs"><span class="icon icon-bp-icons-drugs"></span><span>Drugs</span></a></li>
                  </ul>
               </div>
            </div>
         </nav>
         <div id="mainSearch" class="container">
            <div class="row">
               <div class="col-lg-7">
                  <div class="logo-img"><a href="https://bestpractice.bmj.com/"><span class="remove"><abbr title="British Medical Journal">BMJ</abbr> Best Practice</span></a></div>
               </div>
               <div class="col-lg-5">
                  <style type="text/css">
                     #searchBoxWrap .tt-open:before {content: "Recently viewed topics:"; }
                     #searchBoxWrap .tt-label-override:before,
                     #searchBoxWrap .tt-suggested:before {content: "Suggested topics:" !important; }
                  </style>
                  <form id="searchBoxForm" action="https://bestpractice.bmj.com/search" role="search" novalidate="novalidate">
                     <div class="input-group">
                        <div id="searchBoxWrap">
                           <label for="q" class="sr-only">Search</label>
                           <span class="twitter-typeahead" style="position: relative; display: inline-block;">
                              <input id="q" type="text" name="q" placeholder="Search conditions, symptoms..." value="" class="tt-input" autocomplete="off" spellcheck="false" dir="auto" style="position: relative; vertical-align: top;">
                              <pre aria-hidden="true" style="position: absolute; visibility: hidden; white-space: pre; font-family: sans-serif; font-size: 16px; font-style: normal; font-variant: normal; font-weight: 400; word-spacing: 0px; letter-spacing: 0px; text-indent: 0px; text-rendering: auto; text-transform: none;"></pre>
                              <div class="tt-menu" style="position: absolute; top: 100%; left: 0px; z-index: 100; display: none;">
                                 <div class="tt-dataset tt-dataset-0"></div>
                              </div>
                           </span>
                           <button id="mainSearchBtn" type="submit"><span class="material-icons"></span></button>
                        </div>
                     </div>
                  </form>
                  <script>
                     /*<![CDATA[*/
                     
                            <!-- These are required in completion, see BP-232 -->
                            var searchDefaultLanguageCode = "en-gb";
                            var regionName = "GB and ROW";
                            var regionAvailableLanguagesCodes = [{"id":"1","code":"en-gb","displayName":"English"},{"id":"3","code":"pt-br","displayName":"Portugu\u00EAs"},{"id":"5","code":"es-es","displayName":"Espa\u00F1ol"},{"id":"7","code":"ru-ru","displayName":"\u0420\u0443\u0441\u0441\u043A\u0438\u0439"}];
                            var availableLanguages = [];
                     
                            for (i = 0; i < regionAvailableLanguagesCodes.length; i++) {
                                availableLanguages.push(regionAvailableLanguagesCodes[i].code);
                            }
                     /*]]>*/
                  </script>
               </div>
            </div>
         </div>
         <nav id="mainNav" class="navbar navbar-toggleable-md" role="navigation">
            <div class="container">
               <div id="mainNavbarNav">
                  <ul class="navbar-nav" role="menubar">
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/recent-updates"><span class="icon icon-bp-icons-recent-updates"></span><span>Recent updates</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/specialties"><span class="icon icon-bp-icons-specialties"></span><span>Specialties</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/calculators"><span class="icon icon-bp-icons-calculators"></span><span>Calculators</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/patient-leaflets"><span class="icon icon-bp-icons-patient-leaflets"></span><span>Patient leaflets</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/procedural-videos"><span class="icon icon-bp-icons-procedural-videos"></span><span>Procedural videos</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/evidence"><span class="icon icon-bp-icons-evidence"></span><span>Evidence</span></a></li>
                     <li class="nav-item main" role="menuitem"><a class="nav-link" href="https://bestpractice.bmj.com/drugs"><span class="icon icon-bp-icons-drugs"></span><span>Drugs</span></a></li>
                  </ul>
               </div>
            </div>
         </nav>
      </header>
      <script type="text/javascript" id="">(function(){var f=google_tag_manager["GTM-K3TZ3JV"].macro(4),b=google_tag_manager["GTM-K3TZ3JV"].macro(5),a=function(a,b,d){var e="",c=new Date;d&&(c.setTime(c.getTime()+864E5*d),e="; expires\x3d"+c.toGMTString());document.cookie=a+"\x3d"+b+e+"; path\x3d/; domain\x3dbmj.com"};f?"true"!=b&&("justLoggedIn"==b?a("loggedIn","true",2):a("loggedIn","justLoggedIn",2)):a("loggedIn","false",2)})();</script><script type="text/javascript" id="">var meta=document.createElement("meta");meta.name="msvalidate.01";meta.content="76FD53F39FDFB050A93D7925608BA016";document.getElementsByTagName("head")[0].appendChild(meta);</script>
      <main id="tmp" class="container tmp tmp-basic main-container" role="main">
         <script type="text/javascript">
            /*<![CDATA[*/ 
            var topicId = 17; 
            var langCode="en-gb"; 
            /*]]>*/
         </script>
         <div id="topicNav" class="container">
            <div class="lang">
               <ul role="menu">
                  <li><a href="https://bestpractice.bmj.com/topics/en-gb/17" class="active">English</a></li>
                  <li><a href="https://bestpractice.bmj.com/topics/pt-br/17">Português</a></li>
                  <li><a href="https://bestpractice.bmj.com/topics/es-es/17">Español</a></li>
                  <li><a href="https://bestpractice.bmj.com/topics/ru-ru/17">Русский</a></li>
               </ul>
            </div>
            <div id="topicMenuTopBg" style="height: 110px;"></div>
            <div id="topicMenuTopWrap" style="height: 110px;">
               <div id="topicMenuTop" style="height: 110px;">
                  <h1>Community-acquired pneumonia</h1>
                  <div class="pdf-links-nav">
                     <div class="pdf">
                        <a href="https://bestpractice.bmj.com/topics/en-gb/17/pdf/17.pdf" target="_blank">
                        <span class="icon icon-bp-icons-pdf-extra-small-on-white"></span> <span>View PDF</span>
                        </a>
                     </div>
                  </div>
                  <div id="mobileMenu" class="mUp">
                     <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" role="button">
                     <span><span class="material-icons"></span> Menu</span>
                     <span><span class="material-icons"></span> Close</span>
                     </a>
                  </div>
                  <ul id="menuLinks" role="menu">
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#smenu-0" aria-owns="menu-0">Overview <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#smenu-1" aria-owns="menu-1">Theory <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#smenu-2" aria-owns="menu-2">Diagnosis <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#smenu-3" aria-owns="menu-3">Management <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#smenu-4" aria-owns="menu-4">Follow up <span class="material-icons"></span><span class="material-icons"></span></a></li>
                     <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#smenu-5" aria-owns="menu-5">Resources <span class="material-icons"></span><span class="material-icons"></span></a></li>
                  </ul>
               </div>
            </div>
            <div id="topicMenuBottomWrap" style="height: 208px;">
               <nav id="topicMenuBottom" class="mUp" role="navigation" style="height: 208px;">
                  <ul id="menus" role="menubar">
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" class="parent"><span>Overview</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-0">
                           <li><a href="17_overview_summary.html" id="Summary">Summary</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" class="parent"><span>Theory</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-1">
                           <li><a href="17_theory_epidemiology.html" id="Epidemiology">Epidemiology</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/aetiology" id="Aetiology">Aetiology</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/case-history" id="Case history">Case history</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" class="parent"><span>Diagnosis</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-2">
                           <li><a href="17_diagnosis_recommendations.html" id="Recommendations">Recommendations</a></li>
                           <li><a href="17_diagnosis_history_and_exam.html" id="History and exam">History and exam</a></li>
                           <li><a href="17_diagnosis_investigations.html" id="Investigations">Investigations</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/differentials" id="Differentials">Differentials</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/criteria" id="Criteria">Criteria</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" class="parent"><span>Management</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-3">
                           <li><a href="17_diagnosis_management_recommendations.html" id="Recommendations" class="active">Recommendations</a></li>
                           <li><a href="17_management_treatment_algorithm.html" id="Treatment algorithm">Treatment algorithm</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/emergingtxs" id="Emerging">Emerging</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/prevention" id="Prevention">Prevention</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/patient-discussions" id="Patient discussions">Patient discussions</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" class="parent"><span>Follow up</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-4">
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/monitoring" id="Monitoring">Monitoring</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/complications" id="Complications">Complications</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/prognosis" id="Prognosis">Prognosis</a></li>
                        </ul>
                     </li>
                     <li>
                        <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" class="parent"><span>Resources</span><span class="material-icons"></span><span class="material-icons"></span></a>
                        <ul role="menu" id="menu-5">
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/guidelines" id="Guidelines">Guidelines</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/images-and-videos" id="Images and videos">Images and videos</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/references" id="References">References</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/patient-leaflets" id="Patient leaflets">Patient leaflets</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/calculators" id="Calculators">Calculators</a></li>
                           <li><a href="https://bestpractice.bmj.com/topics/en-gb/17/evidence" id="Evidence">Evidence</a></li>
                        </ul>
                     </li>
                     <li class="mpdf"><a href="https://bestpractice.bmj.com/topics/en-gb/17/pdf/17.pdf" target="_blank"><span class="icon icon-bp-icons-pdf-extra-small-on-white"></span> <span>View PDF</span></a></li>
                  </ul>
               </nav>
            </div>
         </div>
         <h2 id="sr-content">Approach</h2>
         <div class="card">
            <div class="card-block">
               <section>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     When diagnosis of CAP is established, the next step is to determine whether or not the patient requires outpatient care, hospitalisation, or admission to the ICU. Microbial investigation as well as antimicrobial therapy will depend upon the site of care.
                  </p>
               </section>
               <section>
                  <h3>Outpatient selection and management</h3>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Guidelines recommend outpatient treatment for the following patients:
                     <span class="reference"> 
                     <a href="#referencePop4" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[4]</a> 
                     <span class="citationText" aria-hidden="true">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(suppl 2):S27-S72.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://cid.oxfordjournals.org/content/44/Supplement_2/S27.long
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/17278083?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop61" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[61]</a> 
                     <span class="citationText" aria-hidden="true">Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64(suppl 3):iii1-iii55.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://www.brit-thoracic.org.uk/document-library/clinical-information/pneumonia/adult-pneumonia/bts-guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2009-update/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19783532?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <ul class="w-75">
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           Patients in Pneumonia Severity Index (PSI) risk class I or II, with a PSI score ≤70 (low risk), and a predicted 30-day mortality risk of 0.1% to 2.8% 
                           <span class="inlineCalc">
                           <span class="web-link-wrap">
                           <a href="https://bestpractice.bmj.com/calculators/en-gb/CommunityAcqPneumonia.htm">
                           Community-acquired pneumonia severity index (PSI) for adults
                           </a>
                           </span>
                           </span>
                        </p>
                     </li>
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           Patients with a CURB-65 score of 0 to 1 (low severity), and a predicted 30-day mortality risk &lt;3%. (Those with a score of 2 [moderate severity] and a mortality risk of 9% should be considered for brief inpatient care or supervised outpatient care.) 
                           <span class="inlineCalc">
                           <span class="web-link-wrap">
                           <a href="https://bestpractice.bmj.com/calculators/en-gb/CURB65.htm">
                           CURB-65 pneumonia severity score
                           </a>
                           </span>
                           </span>
                        </p>
                     </li>
                  </ul>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Physicians should be aware of the limitations of severity scores and consider the patient’s ability to take oral medication safely and reliably as well as the availability of outpatient support resources when assessing a patient’s suitability for outpatient management.
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Important recommendations for outpatients are not to smoke, to rest, and to stay well hydrated. Patients should also be advised to report any symptoms of chest pain, severe or increasing shortness of breath, or lethargy.
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     In outpatients with appropriate treatment at home, symptoms should improve within 48 hours, at which time reassessment is recommended. Failure to improve within 48 hours should be a consideration for hospital admission.
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Approximately 10% of outpatients do not respond to antibiotic therapy and require hospitalisation.
                     <span class="reference"> 
                     <a href="#referencePop86" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[86]</a> 
                     <span class="citationText" aria-hidden="true">Niederman M. In the clinic: community-acquired pneumonia. Ann Intern Med. 2009 Oct 6;151(7):ITC4-2-ITC4.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19805767?tool=bestpractice.com
                     </span>
                     </span>
                     If the response to therapy is satisfactory, the patient should return within 10 to 14 days for a repeat examination, and a CXR should generally be repeated 1 month after the episode of pneumonia.
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Outpatients who recover without hospitalisation are able to resume normal activities more quickly than those who are hospitalised. Hospitalisation increases the risk of infection with antibiotic-resistant or more virulent bacteria.
                     <span class="reference"> 
                     <a href="#referencePop87" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[87]</a> 
                     <span class="citationText" aria-hidden="true">Halm EA, Teirstein AS. Clinical practice: management of community-acquired pneumonia. N Engl J Med. 2002 Dec 19;347(25):2039-45.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/12490686?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
               </section>
               <section>
                  <h3>Empirical antimicrobial treatment in outpatients</h3>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Recommendations of the American Thoracic Society (ATS)/Infectious Diseases Society of America (IDSA):
                     <span class="reference"> 
                     <a href="#referencePop4" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[4]</a> 
                     <span class="citationText" aria-hidden="true">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(suppl 2):S27-S72.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://cid.oxfordjournals.org/content/44/Supplement_2/S27.long
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/17278083?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <ul class="w-75">
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           Previously healthy patients with low risk of drug-resistant pneumococci should be treated with a macrolide (azithromycin, clarithromycin, or erythromycin) or doxycycline. However, owing to increased rates of resistance, care must be used with the use of macrolides, which are not always appropriate.
                        </p>
                     </li>
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           Patients with a high risk of drug-resistant pneumococci should be treated with a fluoroquinolone (e.g., moxifloxacin, levofloxacin), or a beta-lactam (high-dose amoxicillin or amoxicillin/clavulanic acid is preferred; alternatives include ceftriaxone, cefpodoxime, or cefuroxime) plus a macrolide.
                        </p>
                     </li>
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           Patients with comorbidities, those on immunosuppressant drugs, those who have received antimicrobials within the previous 3 months, and those with other risk factors for drug-resistant pneumococcal infection should be treated with a respiratory fluoroquinolone, or a beta-lactam plus a macrolide. Doxycycline can be used in place of the macrolide.
                        </p>
                     </li>
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           In regions with a high rate (&gt;25%) of infection with high-level (minimum inhibitory concentration [MIC] ≥16 mg/mL) macrolide-resistant 
                           <i>Streptococcus pneumoniae</i>
                           , the use of alternatives to the agents listed above should be considered for any patient, including those without comorbidities.
                        </p>
                     </li>
                  </ul>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     British Thoracic Society (BTS) guidelines recommend that empirical therapy is primarily directed at 
                     <i>S pneumoniae</i>
                     .
                     <span class="reference"> 
                     <a href="#referencePop61" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[61]</a> 
                     <span class="citationText" aria-hidden="true">Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64(suppl 3):iii1-iii55.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://www.brit-thoracic.org.uk/document-library/clinical-information/pneumonia/adult-pneumonia/bts-guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2009-update/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19783532?tool=bestpractice.com
                     </span>
                     </span>
                     Oral amoxicillin is the preferred agent. Doxycycline or clarithromycin are alternatives for patients who are hypersensitive to penicillin.
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Risk factors for penicillin-resistant 
                     <i>S pneumoniae</i>
                     include use of a beta-lactam in the previous 3 to 6 months, hospitalisation in the previous 3 months, aspiration, previous episodes of pneumonia in the past year, age &lt;5 or &gt;65 years, and COPD.
                     <span class="reference"> 
                     <a href="#referencePop88" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[88]</a> 
                     <span class="citationText" aria-hidden="true">Furuya EY, Lowy FD. Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol. 2006 Jan;4(1):36-45.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/16357859?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop89" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[89]</a> 
                     <span class="citationText" aria-hidden="true">Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: does antimicrobial resistance matter? Semin Respir Crit Care Med. 2009 Apr;30(2):210-38.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19296420?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop90" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[90]</a> 
                     <span class="citationText" aria-hidden="true">Fenoll A, Granizo JJ, Aguilar L, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009 Apr;47(4):1012-20.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668361/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19225097?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop91" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[91]</a> 
                     <span class="citationText" aria-hidden="true">Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis. 2008 Dec;8(12):785-95.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19022193?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop92" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[92]</a> 
                     <span class="citationText" aria-hidden="true">Aspa J, Rajas O, de Castro FR. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia. Expert Opin Pharmacother. 2008 Feb;9(2):229-41.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/18201146?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Risk factors for macrolide-resistant 
                     <i>S pneumoniae</i>
                     include use of a macrolide in the previous 3 months, age &lt;5 or &gt;65 years, and recent hospitalisation.
                     <span class="reference"> 
                     <a href="#referencePop88" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[88]</a> 
                     <span class="citationText" aria-hidden="true">Furuya EY, Lowy FD. Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol. 2006 Jan;4(1):36-45.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/16357859?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop89" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[89]</a> 
                     <span class="citationText" aria-hidden="true">Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: does antimicrobial resistance matter? Semin Respir Crit Care Med. 2009 Apr;30(2):210-38.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19296420?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop90" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[90]</a> 
                     <span class="citationText" aria-hidden="true">Fenoll A, Granizo JJ, Aguilar L, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009 Apr;47(4):1012-20.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668361/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19225097?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop91" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[91]</a> 
                     <span class="citationText" aria-hidden="true">Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis. 2008 Dec;8(12):785-95.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19022193?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop92" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[92]</a> 
                     <span class="citationText" aria-hidden="true">Aspa J, Rajas O, de Castro FR. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia. Expert Opin Pharmacother. 2008 Feb;9(2):229-41.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/18201146?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Risk factors for fluoroquinolone-resistant 
                     <i>S pneumoniae</i>
                     include previous exposure to fluoroquinolones, residence in a nursing home, penicillin resistance, and COPD.
                     <span class="reference"> 
                     <a href="#referencePop88" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[88]</a> 
                     <span class="citationText" aria-hidden="true">Furuya EY, Lowy FD. Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol. 2006 Jan;4(1):36-45.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/16357859?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop89" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[89]</a> 
                     <span class="citationText" aria-hidden="true">Lynch JP 3rd, Zhanel GG. Streptococcus pneumoniae: does antimicrobial resistance matter? Semin Respir Crit Care Med. 2009 Apr;30(2):210-38.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19296420?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop90" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[90]</a> 
                     <span class="citationText" aria-hidden="true">Fenoll A, Granizo JJ, Aguilar L, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009 Apr;47(4):1012-20.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668361/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19225097?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop91" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[91]</a> 
                     <span class="citationText" aria-hidden="true">Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis. 2008 Dec;8(12):785-95.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19022193?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop92" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[92]</a> 
                     <span class="citationText" aria-hidden="true">Aspa J, Rajas O, de Castro FR. Pneumococcal antimicrobial resistance: therapeutic strategy and management in community-acquired pneumonia. Expert Opin Pharmacother. 2008 Feb;9(2):229-41.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/18201146?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
               </section>
               <section>
                  <h3>Hospital admission</h3>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Moderately and severely ill patients with CAP should be hospitalised. Guidelines recommend hospital treatment in the following situations:
                     <span class="reference"> 
                     <a href="#referencePop4" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[4]</a> 
                     <span class="citationText" aria-hidden="true">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(suppl 2):S27-S72.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://cid.oxfordjournals.org/content/44/Supplement_2/S27.long
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/17278083?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop61" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[61]</a> 
                     <span class="citationText" aria-hidden="true">Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64(suppl 3):iii1-iii55.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://www.brit-thoracic.org.uk/document-library/clinical-information/pneumonia/adult-pneumonia/bts-guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2009-update/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19783532?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <ul class="w-75">
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           Patients with a PSI score of 71 to 90 (class III), who may benefit from a brief period of hospitalisation 
                           <span class="inlineCalc">
                           <span class="web-link-wrap">
                           <a href="https://bestpractice.bmj.com/calculators/en-gb/CommunityAcqPneumonia.htm">
                           Community-acquired pneumonia severity index (PSI) for adults
                           </a>
                           </span>
                           </span>
                        </p>
                     </li>
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           Patients with PSI class IV or class V pneumonia (who have a 9% and a 27% risk of death, respectively)
                        </p>
                     </li>
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           Patients with a CURB-65 score of ≥3, who should be hospitalised, and those with a score of 4 or 5 (with predicted mortality rates of 15% to 40%, respectively), who should be considered for ICU admission 
                           <span class="inlineCalc">
                           <span class="web-link-wrap">
                           <a href="https://bestpractice.bmj.com/calculators/en-gb/CURB65.htm">
                           CURB-65 pneumonia severity score
                           </a>
                           </span>
                           </span>
                        </p>
                     </li>
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           All patients presenting with hypoxaemia (SaO2 &lt;90% or O2 &lt;60 mmHg) or serious haemodynamic instability, who should be hospitalised regardless of their severity score
                        </p>
                     </li>
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           Patients with CAP caused by high-risk pathogens or those with suppurative or metastatic disease.
                           <span class="reference"> 
                           <a href="#referencePop87" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[87]</a> 
                           <span class="citationText" aria-hidden="true">Halm EA, Teirstein AS. Clinical practice: management of community-acquired pneumonia. N Engl J Med. 2002 Dec 19;347(25):2039-45.</span> 
                           <span class="referenceUniqueId" aria-hidden="true">
                           http://www.ncbi.nlm.nih.gov/pubmed/12490686?tool=bestpractice.com
                           </span>
                           </span>
                        </p>
                     </li>
                  </ul>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Hospitalised patients should receive appropriate oxygen therapy with monitoring of oxygen saturation and inspired oxygen concentration, with the aim of maintaining SaO2 above 92%. High concentrations of oxygen can safely be given in uncomplicated pneumonia.
                     <span class="reference"> 
                     <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" data-trigger="click focus" data-toggle="popover" class="cochranePop" data-original-title="" title="">
                     [ <img src="../images/cca-cochrane-logo-inline.png" alt="Cochrane Clinical Answers logo"> ] 
                     </a>
                     <span class="ccaTitle" aria-hidden="true">What are the effects of noninvasive positive pressure ventilation with supplemental oxygen, when compared with Venturi mask oxygen delivery, in adults with pneumonia?</span>
                     <span class="ccaUrl" aria-hidden="true">/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.73/full</span>
                     <span class="ccaHrefText" aria-hidden="true">Show me the answer</span>
                     </span>
                     Oxygen therapy in patients with COPD that is complicated by ventilatory failure should be guided by repeated arterial blood gas measurements.
                     <span class="reference"> 
                     <a href="#referencePop61" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[61]</a> 
                     <span class="citationText" aria-hidden="true">Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64(suppl 3):iii1-iii55.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://www.brit-thoracic.org.uk/document-library/clinical-information/pneumonia/adult-pneumonia/bts-guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2009-update/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19783532?tool=bestpractice.com
                     </span>
                     </span>
                     Patients with respiratory failure, despite appropriate oxygen therapy, require urgent airway management and possible intubation.
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Patients should be assessed for volume depletion, and intravenous fluids should be administered if needed. Nutritional support should be given in prolonged illness.
                     <span class="reference"> 
                     <a href="#referencePop61" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[61]</a> 
                     <span class="citationText" aria-hidden="true">Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64(suppl 3):iii1-iii55.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://www.brit-thoracic.org.uk/document-library/clinical-information/pneumonia/adult-pneumonia/bts-guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2009-update/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19783532?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Temperature, respiratory rate, pulse, blood pressure, mental status, oxygen saturation, and inspired oxygen concentration should be monitored and recorded, initially at least twice daily and more frequently in patients with severe pneumonia and in those requiring regular oxygen therapy. C-reactive protein (CRP) levels are a sensitive marker of progress in pneumonia and should be measured regularly. CXR should be repeated in patients who are not progressing satisfactorily.
                     <span class="reference"> 
                     <a href="#referencePop61" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[61]</a> 
                     <span class="citationText" aria-hidden="true">Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64(suppl 3):iii1-iii55.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://www.brit-thoracic.org.uk/document-library/clinical-information/pneumonia/adult-pneumonia/bts-guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2009-update/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19783532?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
               </section>
               <section>
                  <h3>Empirical antimicrobial treatment in hospitalised patients not in ICU</h3>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     The recommendation to cover atypical pathogens in the empirical antibiotic regimen is debated;
                     <span class="reference"> 
                     <a href="#referencePop93" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[93]</a> 
                     <span class="citationText" aria-hidden="true">Naucler P, Strålin K. Routine atypical antibiotic coverage is not necessary in hospitalised patients with non-severe community-acquired pneumonia. Int J Antimicrob Agents. 2016 Aug;48(2):224-5.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/27374746?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop94" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[94]</a> 
                     <span class="citationText" aria-hidden="true">Postma DF, van Werkhoven CH, Oosterheert JJ. Community-acquired pneumonia requiring hospitalization: rational decision making and interpretation of guidelines. Curr Opin Pulm Med. 2017 May;23(3):204-10.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/28198726?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop95" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[95]</a> 
                     <span class="citationText" aria-hidden="true">File TM Jr, Marrie TJ. Does empiric therapy for atypical pathogens improve outcomes for patients with CAP? Infect Dis Clin North Am. 2013 Mar;27(1):99-114.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/23398868?tool=bestpractice.com
                     </span>
                     </span>
                     &nbsp;however, the recommendation is supported by current data.
                     <span class="reference"> 
                     <a href="#referencePop96" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[96]</a> 
                     <span class="citationText" aria-hidden="true">File TM Jr, Eckburg PB, Talbot GH, et al. Macrolide therapy for community-acquired pneumonia due to atypical pathogens: outcome assessment at an early time point. Int J Antimicrob Agents. 2017 Aug;50(2):247-51.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/28599867?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference">
                        <a href="#referencePop97" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[97]</a> 
                        <span class="citationText" aria-hidden="true">Eljaaly K, Alshehri S, Aljabri A, et al. Clinical failure with and without empiric atypical bacteria coverage in hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis. BMC Infect Dis. 2017 Jun 2;17(1):385.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                           https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879
                           <rc-c2d-number data-rc-number="-017-2495-5
                              ">-017-2495-5</rc-c2d-number>
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/28576117?tool=bestpractice.com
                        </span>
                     </span>
                     &nbsp;
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     The ATS/IDSA guidelines recommend a beta-lactam (preferred agents are cefotaxime, ceftriaxone, and ampicillin) plus a macrolide. An alternative is monotherapy with a respiratory fluoroquinolone (moxifloxacin or levofloxacin).
                     <span class="reference"> 
                     <a href="#referencePop4" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[4]</a> 
                     <span class="citationText" aria-hidden="true">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(suppl 2):S27-S72.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://cid.oxfordjournals.org/content/44/Supplement_2/S27.long
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/17278083?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" data-trigger="click focus" data-toggle="popover" class="cochranePop" data-original-title="" title="">
                     [ <img src="../images/cca-cochrane-logo-inline.png" alt="Cochrane Clinical Answers logo"> ] 
                     </a>
                     <span class="ccaTitle" aria-hidden="true">In hospitalized adults with community-acquired pneumonia, is there randomized controlled trial evidence to support the use of empiric atypical antibiotic coverage over typical antibiotic coverage?</span>
                     <span class="ccaUrl" aria-hidden="true">/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.306/full</span>
                     <span class="ccaHrefText" aria-hidden="true">Show me the answer</span>
                     </span>
                     In patients with risk factors for methicillin-resistant 
                     <i>Staphylococcus aureus</i>
                     (MRSA) infection, vancomycin or linezolid should be added. Patients at risk for MRSA infection may include men who have sex with men, intravenous drug users, HIV-infected patients, those with an indwelling device or a current wound, those who have been recently hospitalised, those with a chronic illness, and those living in crowded conditions or semi-closed communities. A past history of MRSA infection should also be considered. The epidemiology of MRSA varies geographically.
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     In patients with risk factors for 
                     <i>Pseudomonas</i>
                     infection, an antipneumococcal, antipseudomonal beta-lactam (e.g., piperacillin/tazobactam, cefepime, meropenem) should be given plus either ciprofloxacin or levofloxacin. Alternatively the beta-lactam can be given with an aminoglycoside plus azithromycin or an antipneumococcal fluoroquinolone. Risk factors for 
                     <i>Pseudomonas</i>
                     infection include recent hospitalisation, residence in a nursing home, recent antibiotic use, and advanced chronic respiratory disease, including COPD and bronchiectasis. A past history of 
                     <i>Pseudomonas</i>
                     infection should also be considered. 
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     BTS guideline recommendations for moderate-severity pneumonia (a CURB-65 score of 2) are treatment with amoxicillin plus a macrolide, or monotherapy with a respiratory fluoroquinolone in situations in which other options cannot be prescribed or are ineffective.
                     <span class="reference"> 
                     <a href="#referencePop61" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[61]</a> 
                     <span class="citationText" aria-hidden="true">Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64(suppl 3):iii1-iii55.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://www.brit-thoracic.org.uk/document-library/clinical-information/pneumonia/adult-pneumonia/bts-guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2009-update/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19783532?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
               </section>
               <section>
                  <h3>Empirical antimicrobial treatment in ICU patients</h3>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     ATS/IDSA guidelines recommend a beta-lactam (preferred choices are cefotaxime, ceftriaxone, or ampicillin/sulbactam) plus a macrolide. Alternatively, the beta-lactam can be given with a respiratory fluoroquinolone (moxifloxacin or levofloxacin).
                     <span class="reference"> 
                     <a href="#referencePop4" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[4]</a> 
                     <span class="citationText" aria-hidden="true">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(suppl 2):S27-S72.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://cid.oxfordjournals.org/content/44/Supplement_2/S27.long
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/17278083?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     In patients with risk factors for 
                     <i>Pseudomonas</i>
                     infection, an antipneumococcal, antipseudomonal beta-lactam (e.g., piperacillin/tazobactam, cefepime, meropenem) should be given plus either ciprofloxacin or levofloxacin. Alternatively the beta-lactam can be given with an aminoglycoside plus azithromycin or an antipneumococcal fluoroquinolone.
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     In patients with risk factors for methicillin-resistant 
                     <i>S aureus</i>
                     infection, vancomycin or linezolid should be given. 
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     BTS guidelines recommend treatment with a beta-lactam (cefotaxime, ceftriaxone or ampicillin/sulbactam) plus a respiratory fluoroquinolone.
                     <span class="reference"> 
                     <a href="#referencePop61" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[61]</a> 
                     <span class="citationText" aria-hidden="true">Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64(suppl 3):iii1-iii55.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://www.brit-thoracic.org.uk/document-library/clinical-information/pneumonia/adult-pneumonia/bts-guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2009-update/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19783532?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
               </section>
               <section>
                  <h3>Corticosteroid therapy in hospitalised patients</h3>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Randomised controlled clinical trials suggest that adjunctive corticosteroid therapy can shorten time to clinical stability
                     <span class="reference"> 
                     <a href="#referencePop98" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[98]</a> 
                     <span class="citationText" aria-hidden="true">Blum CA, Nigro N, Briel M, et al. Adjunct prednisone therapy for patients with community-acquired pneumonia: a multicentre, double-blind, randomised, placebo-controlled trial. Lancet. 2015 Apr 18;385(9977):1511-8.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/25608756?tool=bestpractice.com
                     </span>
                     </span>
                     and reduce treatment failure
                     <span class="reference">
                        <a href="#referencePop99" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[99]</a> 
                        <span class="citationText" aria-hidden="true">Torres A, Sibila O, Ferrer M, et al. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial. JAMA. 2015 Feb 17;313(7):677-86.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                           http://jama.jamanetwork.com/article.aspx?articleid
                           <rc-c2d-number data-rc-number="=2110967
                              ">=2110967</rc-c2d-number>
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/25688779?tool=bestpractice.com
                        </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop100" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[100]</a> 
                     <span class="citationText" aria-hidden="true">Torres A, Ferrer M. What's new in severe community-acquired pneumonia? Corticosteroids as adjunctive treatment to antibiotics. Intensive Care Med. 2016 Aug;42(8):1276-8.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/26370691?tool=bestpractice.com
                     </span>
                     </span>
                     among patients admitted to hospital with CAP. 
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Meta-analyses of studies of hospitalised adults with CAP found that the use of corticosteroids was associated with reduced need for mechanical ventilation, reduced hospital stay, lower clinical failure rates, fewer complications, and reduced mortality.
                     <span class="reference"> 
                     <a href="#referencePop101" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[101]</a> 
                     <span class="citationText" aria-hidden="true">Siemieniuk RA, Meade MO, Alonso-Coello P, et al. Corticosteroid therapy for patients hospitalized with community-acquired pneumonia: a systematic review and meta-analysis. Ann Intern Med. 2015 Oct 6;163(7):519-28.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/26258555?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference">
                        <a href="#referencePop102" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[102]</a> 
                        <span class="citationText" aria-hidden="true">Bi J, Yang J, Wang Y, Yao C, et al. Efficacy and safety of adjunctive corticosteroids therapy for severe community-acquired pneumonia in adults: an updated systematic review and meta-analysis. PLoS One. 2016 Nov 15;11(11):e0165942.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                           http://journals.plos.org/plosone/article?id=10.1371/journal.pone
                           <rc-c2d-number data-rc-number=".0165942
                              ">.0165942</rc-c2d-number>
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/27846240?tool=bestpractice.com
                        </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop103" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[103]</a> 
                     <span class="citationText" aria-hidden="true">Briel M, Spoorenberg SMC, Snijders D, et al. Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data meta-analysis. Clin Infect Dis. 2018 Jan 18;66(3):346-354.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/29020323?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop104" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[104]</a> 
                     <span class="citationText" aria-hidden="true">Stern A, Skalsky K, Avni T, et al. Corticosteroids for pneumonia. Cochrane Database Syst Rev. 2017 Dec 13;12:CD007720.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007720.pub3/abstract;jsessionid=E97F2D0357B4F74EC5C27A9A56E8D2D3.f03t02
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/29236286?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" data-trigger="click focus" data-toggle="popover" class="cochranePop" data-original-title="" title="">
                     [ <img src="../images/cca-cochrane-logo-inline.png" alt="Cochrane Clinical Answers logo"> ] 
                     </a>
                     <span class="ccaTitle" aria-hidden="true">How do corticosteroids compare with placebo in adults with pneumonia?</span>
                     <span class="ccaUrl" aria-hidden="true">/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1978/full</span>
                     <span class="ccaHrefText" aria-hidden="true">Show me the answer</span>
                     </span>
                     Another meta-analysis found that adjunct corticosteroid therapy reduced the rate of in-hospital mortality and decreased CRP levels in patients with severe CAP; however, it did not achieve a statistically significant clinical effect or reduction in mechanical ventilation time.
                     <span class="reference"> 
                     <a href="#referencePop105" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[105]</a> 
                     <span class="citationText" aria-hidden="true">Wu WF, Fang Q, He GJ. Efficacy of corticosteroid treatment for severe community-acquired pneumonia: A meta-analysis. Am J Emerg Med. 2017 Jul 15 [Epub ahead of print].</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/28756034?tool=bestpractice.com
                     </span>
                     </span>
                     It appears that the reduction in mortality applies to patients with severe CAP; in patients with non-severe disease, adjunctive corticosteroids reduce morbidity, but not mortality.
                     <span class="reference"> 
                     <a href="#referencePop104" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[104]</a> 
                     <span class="citationText" aria-hidden="true">Stern A, Skalsky K, Avni T, et al. Corticosteroids for pneumonia. Cochrane Database Syst Rev. 2017 Dec 13;12:CD007720.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007720.pub3/abstract;jsessionid=E97F2D0357B4F74EC5C27A9A56E8D2D3.f03t02
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/29236286?tool=bestpractice.com
                     </span>
                     </span>
                     Patients treated with corticosteroids have an increased risk for hyperglycaemia.
                     <span class="reference"> 
                     <a href="#referencePop103" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[103]</a> 
                     <span class="citationText" aria-hidden="true">Briel M, Spoorenberg SMC, Snijders D, et al. Corticosteroids in patients hospitalized with community-acquired pneumonia: systematic review and individual patient data meta-analysis. Clin Infect Dis. 2018 Jan 18;66(3):346-354.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/29020323?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop104" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[104]</a> 
                     <span class="citationText" aria-hidden="true">Stern A, Skalsky K, Avni T, et al. Corticosteroids for pneumonia. Cochrane Database Syst Rev. 2017 Dec 13;12:CD007720.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007720.pub3/abstract;jsessionid=E97F2D0357B4F74EC5C27A9A56E8D2D3.f03t02
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/29236286?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" data-trigger="click focus" data-toggle="popover" class="cochranePop" data-original-title="" title="">
                     [ <img src="../images/cca-cochrane-logo-inline.png" alt="Cochrane Clinical Answers logo"> ] 
                     </a>
                     <span class="ccaTitle" aria-hidden="true">How do corticosteroids compare with placebo in adults with pneumonia?</span>
                     <span class="ccaUrl" aria-hidden="true">/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1978/full</span>
                     <span class="ccaHrefText" aria-hidden="true">Show me the answer</span>
                     </span>
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Corticosteroids should be considered in patients with CAP who present with more severe disease (e.g., matching severe CAP criteria
                     <span class="reference"> 
                     <a href="#referencePop4" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[4]</a> 
                     <span class="citationText" aria-hidden="true">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(suppl 2):S27-S72.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://cid.oxfordjournals.org/content/44/Supplement_2/S27.long
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/17278083?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference">
                        <a href="#referencePop79" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[79]</a> 
                        <span class="citationText" aria-hidden="true">España PP, Capelastegui A, Gorordo I, et al. Development and validation of a clinical prediction rule for severe community-acquired pneumonia. Am J Respir Crit Care Med. 2006 Dec 1;174(11):1249-56.</span> 
                        <span class="citationFullTextUrl" aria-hidden="true">
                           http://www.atsjournals.org/doi/full/10.1164/rccm
                           <rc-c2d-number data-rc-number=".200602-177">.200602-177</rc-c2d-number>
                           OC#.VtNsC-YYGZM
                        </span>
                        <span class="referenceUniqueId" aria-hidden="true">
                        http://www.ncbi.nlm.nih.gov/pubmed/16973986?tool=bestpractice.com
                        </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop80" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[80]</a> 
                     <span class="citationText" aria-hidden="true">Charles PG, Wolfe R, Whitby M, et al. SMART-COP: a tool for predicting the need for intensive respiratory or vasopressor support in community-acquired pneumonia. Clin Infect Dis. 2008 Aug 1;47(3):375-84.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://cid.oxfordjournals.org/content/47/3/375.long
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/18558884?tool=bestpractice.com
                     </span>
                     </span>
                     ) with high levels of an inflammatory marker (e.g., CRP &gt; 150 mg/L).
                  </p>
               </section>
               <section>
                  <h3>Route of antibiotic therapy</h3>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Empirical antibiotic treatment should be started as soon as possible, and should be given in the accident and emergency department to avoid delay. Although it should be noted that shorter time to antibiotic administration has not been associated with a more favorable outcome.
                     <span class="reference"> 
                     <a href="#referencePop106" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[106]</a> 
                     <span class="citationText" aria-hidden="true">Marti C, John G, Genné D, et al. Time to antibiotics administration and outcome in community-acquired pneumonia: secondary analysis of a randomized controlled trial. Eur J Intern Med. 2017 Sep;43:58-61.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/28648477?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     The initial route for antibiotic therapy depends on severity, the patient’s condition, and the site of care. Guidelines recommend that oral antibiotics be used for outpatients while intravenous treatment is preferred for hospitalised patients. However, intravenous treatment should always be given in patients with severe CAP (at least within the initial hours following admission), with daily evaluation for switching to oral medication as soon as possible.
                     <span class="reference"> 
                     <a href="#referencePop4" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[4]</a> 
                     <span class="citationText" aria-hidden="true">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(suppl 2):S27-S72.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://cid.oxfordjournals.org/content/44/Supplement_2/S27.long
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/17278083?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop61" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[61]</a> 
                     <span class="citationText" aria-hidden="true">Lim WS, Baudouin SV, George RC, et al; Pneumonia Guidelines Committee of the BTS Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in adults: update 2009. Thorax. 2009 Oct;64(suppl 3):iii1-iii55.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://www.brit-thoracic.org.uk/document-library/clinical-information/pneumonia/adult-pneumonia/bts-guidelines-for-the-management-of-community-acquired-pneumonia-in-adults-2009-update/
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/19783532?tool=bestpractice.com
                     </span>
                     </span>
                     Patients may be changed to oral therapy when they are haemodynamically stable and improving clinically, can ingest oral medications, and have a normally functioning gastrointestinal tract.
                     <span class="reference"> 
                     <a href="#referencePop4" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[4]</a> 
                     <span class="citationText" aria-hidden="true">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(suppl 2):S27-S72.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://cid.oxfordjournals.org/content/44/Supplement_2/S27.long
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/17278083?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
               </section>
               <section>
                  <h3>Duration of antibiotic therapy</h3>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     The duration of therapy should be a minimum of 5 days.
                     <span class="reference"> 
                     <a href="#referencePop4" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[4]</a> 
                     <span class="citationText" aria-hidden="true">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(suppl 2):S27-S72.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://cid.oxfordjournals.org/content/44/Supplement_2/S27.long
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/17278083?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop107" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[107]</a> 
                     <span class="citationText" aria-hidden="true">Uranga A, España PP, Bilbao A, et al. Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial. JAMA Intern Med. 2016 Sep 1;176(9):1257-65.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/27455166?tool=bestpractice.com
                     </span>
                     </span>
                     Consideration can then be given to discontinuing therapy, providing that the patient has been afebrile for 48 to 72 hours and there is no sign of complications (endocarditis, meningitis). Also, in cases of pneumonia due to specific pathogens such as 
                     <i>Legionella</i>
                     species, 
                     <i>Pseudomonas aeruginosa</i>
                     , or 
                     <i>S aureus</i>
                     , prolonged antimicrobial therapy is recommended. Consultation with an infectious diseases expert is warranted in these cases.
                  </p>
               </section>
               <section>
                  <h3>Microbiologically directed therapy</h3>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Patients in whom laboratory tests have revealed a causative organism may be switched to an organism-specific therapy guided by antibiotic sensitivity.
                  </p>
               </section>
               <section>
                  <h3>Non-responding pneumonia</h3>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Non-responding CAP describes the clinical situation where there is an inadequate response after antibiotic treatment as assessed at day 3 to day 5. The causes of non-responding pneumonia are classified as infectious, non-infectious, and of unknown origin. Multicentre studies have shown that between 6% and 24% of CAP cases will not respond to antibiotic treatment, and in cases of severe pneumonia, this rate can reach 31%.
                     <span class="reference"> 
                     <a href="#referencePop23" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[23]</a> 
                     <span class="citationText" aria-hidden="true">Torres A, Barberán J, Falguera M, et al. Multidisciplinary guidelines for the management of community-acquired pneumonia [in Spanish]. Med Clin (Barc). 2013 Mar 2;140(5):223.e1-223.e19.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/23276610?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop108" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[108]</a> 
                     <span class="citationText" aria-hidden="true">Aliberti S, Blasi F. Clinical stability versus clinical failure in patients with community-acquired pneumonia. Semin Respir Crit Care Med. 2012 Jun;33(3):284-91.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/22718214?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     One study has described 2 different clinical patterns of non-responding pneumonia:
                     <span class="reference"> 
                     <a href="#referencePop109" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[109]</a> 
                     <span class="citationText" aria-hidden="true">Menendez R, Torres A. Treatment failure in community-acquired pneumonia. Chest. 2007 Oct;132(4):1348-55.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/17934120?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <ul class="w-75">
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           Progressive pneumonia that follows a course of clinical deterioration with respiratory failure or septic shock
                        </p>
                     </li>
                     <li>
                        <p class="w-75">
                           <!-- col-md-9 -->
                           The situation where clinical stability is not achieved and no other patient characteristics are responsible.
                        </p>
                     </li>
                  </ul>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     Biomarkers such as CRP and procalcitonin (PCT) have been found to be useful for predicting inadequate host response. High levels of CRP or PCT at initial presentation represent a risk factor for inadequate response,
                     <span class="reference"> 
                     <a href="#referencePop69" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[69]</a> 
                     <span class="citationText" aria-hidden="true">Menéndez R, Cavalcanti M, Reyes S, et al. Markers of treatment failure in hospitalised community acquired pneumonia. Thorax. 2008 May;63(5):447-52.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://thorax.bmj.com/content/63/5/447.long
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/18245147?tool=bestpractice.com
                     </span>
                     </span>
                     whereas low levels are protective. The use of procalcitonin to guide initiation and duration of antibiotic treatment results in a lower risk of mortality, lower antibiotic consumption, and lower risk for side effects.
                     <span class="reference"> 
                     <a href="#referencePop110" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[110]</a> 
                     <span class="citationText" aria-hidden="true">Schuetz P, Wirz Y, Sager R, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017 Oct 12;(10):CD007498.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD007498.pub3/abstract
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/29025194?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="#referencePop111" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[111]</a> 
                     <span class="citationText" aria-hidden="true">Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2017 Oct 13 [Epub ahead of print].</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/29037960?tool=bestpractice.com
                     </span>
                     </span>
                     <span class="reference"> 
                     <a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" data-trigger="click focus" data-toggle="popover" class="cochranePop" data-original-title="" title="">
                     [ <img src="../images/cca-cochrane-logo-inline.png" alt="Cochrane Clinical Answers logo"> ] 
                     </a>
                     <span class="ccaTitle" aria-hidden="true">How does procalcitonin testing affect antibiotic use and other outcomes for people with acute respiratory infection?</span>
                     <span class="ccaUrl" aria-hidden="true">/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.1971/full</span>
                     <span class="ccaHrefText" aria-hidden="true">Show me the answer</span>
                     </span>
                     However, one review found no difference in short-term mortality in critically ill patients specifically,
                     <span class="reference"> 
                     <a href="#referencePop112" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[112]</a> 
                     <span class="citationText" aria-hidden="true">Lam SW, Bauer SR, Fowler R, et al. Systematic review and meta-analysis of procalcitonin-guidance versus usual care for antimicrobial management in critically ill patients: focus on subgroups based on antibiotic initiation, cessation, or mixed strategies. Crit Care Med. 2018 Jan 2.</span> 
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/29293146?tool=bestpractice.com
                     </span>
                     </span>
                     while another study found that PCT-guided therapy did not result in decreased use of antibiotics.
                     <span class="reference"> 
                     <a href="#referencePop113" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[113]</a> 
                     <span class="citationText" aria-hidden="true">Huang DT, Yealy DM, Filbin MR, et al. Procalcitonin-guided use of antibiotics for lower respiratory tract infection. N Engl J Med. 2018 Jul 19;379(3):236-249.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     https://escholarship.org/uc/item/9bd679z6
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/29781385?tool=bestpractice.com
                     </span>
                     </span>
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                     The first response to non-response or deterioration should be to re-evaluate the initial microbiology results.
                     <span class="reference"> 
                     <a href="#referencePop4" data-trigger="click focus" data-toggle="popover" class="referencePop" data-original-title="" title="">[4]</a> 
                     <span class="citationText" aria-hidden="true">Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007 Mar 1;44(suppl 2):S27-S72.</span> 
                     <span class="citationFullTextUrl" aria-hidden="true">
                     http://cid.oxfordjournals.org/content/44/Supplement_2/S27.long
                     </span>
                     <span class="referenceUniqueId" aria-hidden="true">
                     http://www.ncbi.nlm.nih.gov/pubmed/17278083?tool=bestpractice.com
                     </span>
                     </span>
                     Results of cultures and sensitivity testing that were not available at presentation may now make the cause of clinical failure obvious. In addition, a further history of any risk factors for infection with unusual micro-organisms, including viruses, should be sought if this has not already been done. Further diagnostic testing may also be warranted. 
                  </p>
                  <p class="w-75">
                     <!-- col-md-9 -->
                  </p>
                  <hr class="fw">
                  <span class="inlineVid">
                  <a href="https://bestpractice.bmj.com/procedural-videos/en-gb/129b1e64-893a-4a65-b198-d27e27f17088">
                  <img src="../images/129b1e64-893a-4a65-b198-d27e27f17088.jpg" class="pr-3" alt="Bag-valve-mask ventilation animated demonstration">
                  Bag-valve-mask ventilation animated demonstration 
                  </a>
                  </span>
                  <hr class="fw">
                  <hr class="fw">
                  <span class="inlineVid">
                  <a href="https://bestpractice.bmj.com/procedural-videos/en-gb/67fc9278-908e-48af-8752-085b1de23b79">
                  <img src="../images/67fc9278-908e-48af-8752-085b1de23b79.jpg" class="pr-3" alt="Tracheal intubation animated demonstration">
                  Tracheal intubation animated demonstration 
                  </a>
                  </span>
                  <hr class="fw">
                  <hr class="fw">
                  <span class="inlineVid">
                  <a href="https://bestpractice.bmj.com/procedural-videos/en-gb/c1193f56-cb5c-4717-b14e-4fff8ae92e38">
                  <img src="../images/c1193f56-cb5c-4717-b14e-4fff8ae92e38.jpg" class="pr-3" alt="Central venous catheter insertion animated demonstration">
                  Central venous catheter insertion animated demonstration 
                  </a>
                  </span>
                  <hr class="fw">
                  <hr class="fw">
                  <span class="inlineVid">
                  <a href="https://bestpractice.bmj.com/procedural-videos/en-gb/eaf808b3-4db7-4604-9ceb-b15fe298e8d0">
                  <img src="../images/eaf808b3-4db7-4604-9ceb-b15fe298e8d0.jpg" class="pr-3" alt="Peripheral venous cannulation animated demonstration">
                  Peripheral venous cannulation animated demonstration 
                  </a>
                  </span>
                  <hr class="fw">
               </section>
            </div>
         </div>
         <div class="card-block disclaimer">
            <p><span>Use of this content is subject to our <a href="https://bestpractice.bmj.com/info/disclaimer/" target="_blank">disclaimer</a> </span></p>
         </div>
      </main>
      <!-- set the messages country code variable from region to be used from i18 plugin. Setting here so it's available in all pages -->
      <script>
         /*<![CDATA[*/
         
         var messagesCountryCode = "en_GB";
         /*]]>*/
           
      </script>
      <aside id="panel-nhs" class="card-block">
         <div id="access" class="col-sm-6">
            <div class="row">
               <div class="col-md-6">
                  <p>Access provided by:</p>
               </div>
               <div class="col-md-6">
                  <img src="../images/bmj-logo.png" alt="BMJ Group (Online access from BMA House)">
               </div>
            </div>
         </div>
      </aside>
      <footer id="footer">
         <div class="container">
            <div class="row">
               <nav class="col-md-9" role="navigation">
                  <div class="row">
                     <dl class="col-md-4" role="menu">
                        <dt>Browse</dt>
                        <dd><a href="https://bestpractice.bmj.com/">Home</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/recent-updates">Recent updates</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/specialties">Specialties</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/calculators">Calculators</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/patient-leaflets">Patient leaflets</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/procedural-videos">Procedural videos</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/evidence">Evidence</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/drugs">Drugs</a></dd>
                     </dl>
                     <!-- logged-in individual or institutional user -->
                     <!-- unknown user -->
                     <!--institutional user not logged in-->
                     <dl class="col-md-4" role="menu">
                        <dt>Services</dt>
                        <dd><a href="https://bestpractice.bmj.com/login">Log in</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/registration">Create an account</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/getting-started/" target="_blank">Getting started</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/faq/" target="_blank">FAQs</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/benefits-features/earn-cme-points/" target="_blank">About CME/CPD</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/benefits-features/" target="_blank">About us</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/app/" target="_blank">Mobile app</a></dd>
                        <dd><a href="https://bestpractice.bmj.com/info/contact-us/" target="_blank">Contact us</a></dd>
                        <dd>
                           <a href="https://myaccount.bmj.com/myaccount/registration.html?regService=bestpractice-email-alert&amp;fwdUrl=https://bestpractice.bmj.com">
                           Sign up for email alerts
                           </a>
                        </dd>
                     </dl>
                     <dl class="col-md-4" role="menu">
                        <dt>Legal</dt>
                        <dd><a href="https://bestpractice.bmj.com/info/disclaimer/" target="_blank">Disclaimer</a></dd>
                        <dd><a href="https://www.bmj.com/company/legal-information/" target="_blank">Terms and conditions</a></dd>
                        <dd><a href="https://www.bmj.com/company/your-privacy/" target="_blank">Privacy notice</a></dd>
                        <dd><a href="https://www.bmj.com/company/your-privacy/cookies-policy/" target="_blank">Cookie policy</a></dd>
                     </dl>
                  </div>
                  <!-- row -->
               </nav>
               <div class="col-md-3">
                  <ul>
                     <li><a target="_blank" href="https://www.facebook.com/BMJBestPractice"><img alt="Facebook Logo" title="Facebook" src="../images/facebook-64.png" width="60" height="60"></a></li>
                     <li><a target="_blank" href="https://twitter.com/BMJBestPractice"><img alt="Twiter Logo" title="Twitter" src="../images/twitter-64.png" width="60" height="60"></a></li>
                     <li><a target="_blank" href="https://www.linkedin.com/showcase/15218227/"><img alt="LinkedIn Logo" title="LinkedIn" src="../images/linkedIn_logo_circle.png" width="60" height="60"></a></li>
                     <li><a target="_blank" href="https://www.youtube.com/channel/UCt72GZ0cPXpk4EzgFhdWYdQ"><img alt="Youtube Logo" title="YouTube" src="../images/youtube-64.png" width="60" height="60"></a></li>
                  </ul>
                  <p class="copyright mt-3"><small>© BMJ Publishing Group 2018</small></p>
                  <p class="issn">
                     <small>
                        ISSN
                        <rc-c2d-number data-rc-number=" 2515-9615"> 2515-9615</rc-c2d-number>
                     </small>
                  </p>
               </div>
            </div>
            <!-- row -->  
         </div>
         <!-- container -->    
      </footer>
      <div class="container modal-registration-form" aria-hidden="true">
         <div id="feedbackContainer" class="modal fade" tabindex="-1" role="dialog" aria-labelledby="ModalFeedbackLabel" aria-hidden="true">
            <div class="modal-dialog modal-lg" role="document">
               <div class="modal-content pb-3">
                  <div class="modal-header">
                     <div class="row">
                        <div class="col-md-12">
                           <h2>Help us improve <abbr>BMJ</abbr> Best Practice</h2>
                           <button type="button" class="close" data-dismiss="modal" aria-label="Close">
                           <span aria-hidden="true">×</span>
                           </button>
                        </div>
                        <div class="col-md-12">
                           <p>Please complete all fields.</p>
                        </div>
                     </div>
                  </div>
                  <div class="modal-body">
                     <div class="row">
                        <div class="col-md-12">
                           <form id="feedbackForm" action="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#" novalidate="novalidate">
                              <div class="row">
                                 <div class="col-md-6">
                                    <div class="form-group floating-label">
                                       <label for="feedbackName">Name</label> 
                                       <input id="feedbackName" class="form-control" name="feedbackName" type="text">
                                    </div>
                                 </div>
                                 <div class="col-md-6">
                                    <div class="form-group floating-label">
                                       <label for="feedbackEmail">Email</label> 
                                       <input id="feedbackEmail" class="form-control" name="feedbackEmail" type="email" value="">
                                    </div>
                                 </div>
                              </div>
                              <div class="row">
                                 <div class="col-md-12">
                                    <h2 id="feedbackPageTitle" class="h3">Page: Community-acquired pneumonia - Approach | BMJ Best Practice</h2>
                                 </div>
                              </div>
                              <input id="feedbackPage" name="feedbackPage" type="hidden" value="Community-acquired pneumonia - Approach | BMJ Best Practice">
                              <div class="row">
                                 <div class="col-md-4">
                                    <p>I have some feedback on:</p>
                                    <fieldset class="form-group" role="radiogroup">
                                       <legend>Feedback on: </legend>
                                       <label for="feedOn01"><input id="feedOn01" type="radio" name="feedbackOn" value="This page" checked="checked">&nbsp;This page</label>
                                       <label for="feedOn02"><input id="feedOn02" type="radio" name="feedbackOn" value="This website">&nbsp;The website in general</label>
                                       <label for="feedOn03"><input id="feedOn03" type="radio" name="feedbackOn" value="Something else">&nbsp;Something else</label>
                                    </fieldset>
                                 </div>
                                 <div class="col-md-8">
                                    <div class="form-group floating-label textarea">
                                       <label for="feedbackContent">I have some feedback on:</label>
                                       <textarea id="feedbackContent" name="feedbackContent"></textarea>
                                    </div>
                                 </div>
                              </div>
                              <div class="row">
                                 <div class="col-md-12">
                                    <p>We will respond to all feedback.</p>
                                 </div>
                              </div>
                              <div class="row">
                                 <div class="col-md-12">
                                    <button id="feedbackSubmit" type="submit" class="btn btn-secondary btn-lg">
                                    <span id="spinner2" class="progress-circular-inner progress-circular-left"></span>
                                    <span id="btnText2">Submit Feedback</span>
                                    </button>
                                 </div>
                              </div>
                              <div class="row smTxt">
                                 <div class="col-md-12">
                                    <p>For any urgent enquiries please contact our customer services team who are ready to help with any problems.</p>
                                 </div>
                              </div>
                              <div class="row smTxt">
                                 <div class="col-md-3">
                                    <p>
                                       <b>Phone:</b> 
                                       <rc-c2d-number data-rc-number="+44 (0) 207 111 1105">+44 (0) 207 111 1105</rc-c2d-number>
                                    </p>
                                 </div>
                                 <div class="col-md-3">
                                    <p><b>Email: </b> <a href="mailto:support@bmj.com">support@bmj.com</a></p>
                                 </div>
                              </div>
                           </form>
                        </div>
                     </div>
                  </div>
               </div>
            </div>
         </div>
         <div id="feedbackSuccess" class="modal fade" tabindex="-1" role="dialog" aria-labelledby="ModalFeedbackConfirmedLabel" aria-hidden="true">
            <div class="modal-dialog modal-lg" role="document">
               <div class="modal-content pb-3">
                  <div class="modal-body">
                     <div class="row">
                        <div class="col-md-12">
                           <h2>Thank you</h2>
                           <button type="button" class="close" data-dismiss="modal" aria-label="Close">
                           <span aria-hidden="true">×</span>
                           </button>
                        </div>
                     </div>
                     <div class="row">
                        <div class="col-md-12">
                           <p>Your feedback has been submitted successfully.</p>
                        </div>
                     </div>
                  </div>
               </div>
            </div>
         </div>
         <div id="feedBackBtn">
            <p role="button"><a href="https://bestpractice.bmj.com/topics/en-gb/17/management-approach#"><span class="material-icons"></span>&nbsp;FEEDBACK</a></p>
         </div>
      </div>
      <script type="text/javascript" src="../js/common.js"></script>
      <script type="text/javascript" src="../js/main.js"></script>
      <script>
         // Code for the recently viewed topics suggestion, needs to be inlined to use the Java values
         /*<![CDATA[*/       
         function dedupe(array) {
           var seen = {};
           return array.filter(function(item) {
               return seen.hasOwnProperty(item.id) ? false : (seen[item.id] = true);
           });
         }
         function TopicViewed(id, title, lang) {
           this.id = id;
           this.title = title;
           this.lang = lang;
         }
         jQuery(document).ready(function() {
           var topicId = 17;
           var topicLang = "en-gb";
           var topicTitle = "Community-acquired pneumonia";
           if(topicId){
               
             var topicsViewed = [];
             if (localStorage.getItem("topicsViewed") !== null) {
               topicsViewed = JSON.parse(localStorage.topicsViewed);
             }
               
             topicsViewed.unshift(new TopicViewed(topicId, topicTitle, topicLang));// Add new topics at the beginning
             topicsViewed = dedupe(topicsViewed);// Remove duplicates
             if (topicsViewed.length > 15){// Drop if size is bigger than 15
               topicsViewed = topicsViewed.slice(0,14);  
             }
         
             localStorage.topicsViewed = JSON.stringify(topicsViewed);
           }
          });       
         /*]]>*/
      </script>
      <script type="text/javascript">
         _linkedin_data_partner_id = "103646";
      </script>
      <script type="text/javascript">
         (function()
         {var s = document.getElementsByTagName("script")[0]; var b = document.createElement("script"); b.type = "text/javascript";b.async = true; b.src = "https://snap.licdn.com/li.lms-analytics/insight.min.js"; s.parentNode.insertBefore(b, s);}
         )();
      </script>
      <script type="text/javascript" data-cfasync="false">
         (function(W,i,s,e,P,o,p){W['WisePopsObject']=P;W[P]=W[P]||function()
         { (W[P].q=W[P].q||[]).push(arguments)}
         ,W[P].l=1*new Date();o=i.createElement(s),
         p=i.getElementsByTagName(s)[0];o.async=1;o.src=e;p.parentNode.insertBefore(o,p)
         })(window,document,'script','//loader.wisepops.com/get-loader.js?v=1&site=qudyiEfMBd','wisepops');
         window.WisePopsLoaderCallback = function(wisepops) {
                         wisepops._storage.visits = wisepops._storage.visits.slice(0, 2);
                         wisepops._storage._saveVisits();
                       };
      </script>
      <noscript>
         <img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=103646&fmt=gif" />
      </noscript>
      <!--[if lte IE 7]><script>var isIE7OrOlder = true; </script><![endif]-->   
      <!--[if lte IE 9]><script type="text/javascript" src="/gzip_e7393341757851d76c3264b590cf5143/js/browserupdate.js" ></script>
      <![endif]-->
      <script src="../js/adsct.js" type="text/javascript"></script><script type="text/javascript" id="createCookie">(function(){var b="bestpractice.bmj.com\/topics\/en-gb\/17\/management-approach",a=function(a,b,d){var e="",c=new Date;d&&(c.setTime(c.getTime()+864E5*d),e="; expires\x3d"+c.toGMTString());document.cookie=a+"\x3d"+b+e+"; path\x3d/; domain\x3dbmj.com"};a("RefTrack",b,2);a("RefTrackGroup","bestpractice.bmj.com",2)})();</script><script type="text/javascript" id="copyText">function getSelectionText(){var a="";window.getSelection?a=window.getSelection().toString():document.selection&&"Control"!=document.selection.type&&(a=document.selection.createRange().text);return a}document.addEventListener("copy",function(a){dataLayer.push({event:"textCopied",clipboardText:getSelectionText(),clipboardLength:getSelectionText().length})});</script>
      <script type="text/javascript" id="facebookPixel">!function(b,e,f,g,a,c,d){b.fbq||(a=b.fbq=function(){a.callMethod?a.callMethod.apply(a,arguments):a.queue.push(arguments)},b._fbq||(b._fbq=a),a.push=a,a.loaded=!0,a.version="2.0",a.queue=[],c=e.createElement(f),c.async=!0,c.src=g,d=e.getElementsByTagName(f)[0],d.parentNode.insertBefore(c,d))}(window,document,"script","https://connect.facebook.net/en_US/fbevents.js");fbq("init","414393182248444");fbq("track","PageView");</script>
      <noscript><img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=414393182248444&amp;ev=PageView&amp;noscript=1"></noscript>
      <button id="scrollTop" class="material-scrolltop" type="button"><span class="material-icons"></span></button>
      <rc-c2d-menu class="_6772342E312E39_src-lib-ExtensionContentRunner-styles__c2dMenu--2ChJF">
         <div class="_6772342E312E39_src-lib-ExtensionContentRunner-styles__c2dMenuWrapper--2XS05">
            <img class="_6772342E312E39_src-lib-ExtensionContentRunner-styles__c2dLogo--3d0gU" src="data:image/png;base64,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">
            <div class="_6772342E312E39_src-lib-ExtensionContentRunner-styles__callBtn--g4JAI _6772342E312E39_src-lib-ExtensionContentRunner-styles__visible--1Jw-v" title="Call with RingCentral">
               <svg xmlns="http://www.w3.org/2000/svg" width="18" height="18" viewBox="0 0 24 26">
                  <path fill="#0083BF" fill-rule="evenodd" stroke="#0684BD" stroke-width=".9" d="M6.656 17.651C.942 10.547.28 4.627 2.545 2.607c.592-.522 2.16-1.323 2.892-1.427.801-.14 1.602.243 2.02 1.01.802 1.636 1.777 3.238 2.788 4.805.452.697.348 1.567-.244 2.16-.349.348-.767.557-1.15.765a3.18 3.18 0 0 0-.801.523s-.105.104-.105.313c-.035.453.035 1.707 2.02 4.214 2.16 2.647 3.45 2.82 3.798 2.82.14 0 .244-.034.244-.034.244-.21.453-.453.662-.697.314-.348.593-.696 1.01-.975.697-.452 1.638-.348 2.16.21 1.325 1.323 2.753 2.576 4.112 3.76.662.557.906 1.428.557 2.16-.244.66-1.359 2.02-2.02 2.541-.558.488-1.324.697-2.195.697-3.345 0-7.7-2.925-11.637-7.8z"></path>
               </svg>
            </div>
            <div class="_6772342E312E39_src-lib-ExtensionContentRunner-styles__separatorLine--wHeg7 _6772342E312E39_src-lib-ExtensionContentRunner-styles__visible--1Jw-v"></div>
            <div class="_6772342E312E39_src-lib-ExtensionContentRunner-styles__smsBtn--b7MAc _6772342E312E39_src-lib-ExtensionContentRunner-styles__visible--1Jw-v" title="SMS with RingCentral">
               <svg xmlns="http://www.w3.org/2000/svg" width="18" height="18" viewBox="0 0 22 21">
                  <path fill="#0684BD" fill-rule="nonzero" d="M10.944.014C4.91.014.007 4.068.007 9.316c0 2.86 1.54 5.626 4.085 7.417-.094.534-.377 1.257-1.162 2.64l-.692 1.131h1.383a6.976 6.976 0 0 0 4.84-1.917c.817.157 1.634.252 2.483.252 6.034 0 10.936-4.275 10.936-9.523 0-5.28-4.902-9.302-10.936-9.302z"></path>
               </svg>
            </div>
         </div>
         <div class="_6772342E312E39_src-lib-ExtensionContentRunner-styles__arrow--1GYRr">
            <div class="_6772342E312E39_src-lib-ExtensionContentRunner-styles__innerArrow--2JsQO"></div>
         </div>
      </rc-c2d-menu>
      <script src="../js/saved_resource.js" type="text/javascript"></script>
   </body>
</html>